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Protein-misfolding, aggregation and accumulation of insoluble deposits are the hallmark fea-
tures of a variety of human diseases such as Parkinson's disease and diabetes mellitus type 
II. The latter is a systemic disorder characterized by insulin resistance, impaired insulin se-
cretion, -cell apoptosis and islet amyloid formation. Fibrillar aggregates from the self-
assembly of human islet amyloid polypeptide (hIAPP) are major component of islet amyloids. 
Accumulating evidence suggests that not the mature fibrils, but rather smaller, soluble, poly-
morphic and highly dynamic oligomers preceding the formation of the fibrils are the cytotoxic 
species. A detailed insight into the structures of the oligomeric intermediates is crucial for 
identification of potential targets and development of therapeutic strategies. However, the 
polydisperse nature of these peptides makes their structural characterization challenging. 
The traditional condensed-phase analytical techniques provide only averaged structural in-
formation on the dynamic ensemble. However, information on the structure of isolated spe-
cies can be obtained by employing gas-phase techniques. Here, infrared action spectroscopy 
in combination with ion-mobility spectrometry is used to gain insight into the secondary struc-
ture of these isolated peptides. The orthogonal combination of these techniques allows to 
obtain fingerprint vibrational spectra of m/z- and conformer-selected species. The secondary 
structure of the full-length hIAPP, as well as of metal-associated hIAPP and  hIAPP in heter-
ogeneous co-assemblies with a fragment of the prion protein (PrP106-126) and the hexapeptide 
VEALYL were investigated. The obtained data suggests that the secondary structure of the 
monomeric hIAPP contains a significant fraction of -helical motifs, which is seemingly main-
tained upon metal binding, self-assembly, or heterogeneous co-assembly with other pep-
tides. These results provide solid evidence for the importance of helical intermediates in the 
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Diabetes mellitus type II (T2D), Parkinson's disease (PD), Alzheimer's disease (AD) and 
other neurodegenerative diseases share as a common pathological characteristic the 
formation of amyloid plaques. These amyloid plaques consist of insoluble aggregates of 
fibrous morphology rich in -sheet secondary structures.[1-3] Considering the observation 
of these structures in vivo, they were for a long time considered to be the toxic species 
behind those pathologies.[4] However, studies carried out in recent years have shown 
that the neurotoxic species are the intermediary structures that anticipate the formation 
of fibrillary aggregates.[4] These species are highly dynamic and polydisperse oligomers 
ranging from dimers to protofibrils. Elucidating the precise structure of pre-fibrillar oligo-
mers and the mechanism that leads monomers to fibrils is crucial not only for the selec-
tive modulation of the aggregation process, but also helps to clarify fundamental ques-
tions about the nature of protein folding.[5, 6] 
However, due to their polydisperse, polymorphic and transient nature, these pre-fibrillar 
oligomers exist in rapid equilibrium between different stoichiometric and conformational 
states.[7] The characterization of the soluble oligomers using condensed-phase tech-
niques does not provide structural information of the oligomeric species individually, but 
rather, average information of the ensemble.[5, 8] In order to obtain structural information 
on isolated species, gas-phase techniques, especially ion mobility spectrometry coupled 
to mass spectrometry (IM-MS), have been employed in the analysis and characterization 
of isolated oligomers in the presence of other species. The combination of these two 
techniques allows the selection of molecular ions based on their mass as well as on their 
shape and spatial conformations. Therefore IM-MS turned out to be an outstanding tool 
for the analysis of non-covalently associated protein complexes.[9] The ability of this 
technique relies on the advent of soft-ionization methods such as electrospray ionization 
(ESI), which allows the transfer of biomolecules from solution into the gas-phase envi-
ronment while keeping its native structure. Yet, this analytical approach itself does not 
provide direct information on the motifs making up the secondary structures of individual 
toxic oligomers. To overcome this limitation, IM-MS can further be coupled to other or-
thogonal analytical techniques, such as infrared spectroscopy. Highly secondary struc-
ture-sensitive gas-phase IR spectroscopy is then performed on m/z- and conformer-
preselected early oligomeric intermediates of amyloid-forming species. 
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One example among well-studied amyloid-forming peptides is the human islet amyloid 
polypeptide (hIAPP), the major protein component of pancreatic islet amyloidosis which 
is associated with the pathogeny of type II diabetes (T2D).[10] Pancreatic islet amyloidosis 
contributes to -cell dysfunction, cell death, progression of T2D as well as to other com-
plications.[4] In its native state, hIAPP is soluble and mainly monomeric but forms islet 
amyloids in T2D. Still, little is known about the molecular nature of the toxic hIAPP spe-
cies, the mechanism of hIAPP amyloid formation and the mechanism of cytotoxicity is 
not fully understood. However, it has been settled that its toxicity is conformation-
dependent.[4] In addition, hIAPP shares the same secretory pathway with the hormone 
insulin and also high concentrations of zinc and copper ions have been detected in the 
pancreatic -cells.[11] These findings raise the question about the role of metal binding 
and heterogeneous co-association of peptides on hIAPP aggregation.  
In this thesis, the structures of early hIAPP intermediates were investigated by a combi-
nation of gas-phase techniques, namely IM-MS and IR spectroscopy and furthermore by 
traditional condensed-phase IR spectroscopy. Likewise, the effect of metal-association 
and hetero-oligomerization on the aggregation behavior of the investigated intermediates 
is investigated in the course of the presented work.  
2. FUNDAMENTALS 
 
2.1 The Amyloid State of Human Islet Amyloid Polypep-
tide 
2.1.1 AMYLOID DEFINITION 
 
Several neurodegenerative and systemic disorders such as Alzheimer’s and Parkinson’s 
disease, prion disease and type 2 diabetes mellitus share the deposition of amyloid 
plaques as their primary trait. The term amyloid was first used to describe abnormal ex-
tracellular deposits of insoluble proteins showing an amylopectin-like aspect.[10] These 
proteins entering the so-called amyloid state are referred to as intrinsically disordered 
proteins (IDPs) and in the amyloids found in vivo they form elongated, unbranched fibers 
composed of many-stranded -sheets.[1, 12] This operational definition of amyloid has 
been adopted by the community of pathologists.[1] Additionally, the amyloid fibrils bind 
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the dye Congo red or thioflavine T (ThT) and show green birefringence when viewed 
between polarizers.[12] 
Since amyloid formation has also been observed in vitro and similar fibers are formed by 
denatured proteins[13], a molecular-based definition has been adopted by biophysicists. 
This definition excludes the requirement that the fibers have to be extracellular and dis-
ease related. According to this structure-related definition, amyloid fibers display the 
cross-fiber diffraction pattern (Figure 1)[1], an X-ray diffraction signature.[14] This pattern 
reveals that the fibril’s most notable repeating feature is a set of -sheets parallel to the 
fiber axis. The hydrogen-bonded strands are perpendicular to this axis and the -sheets 
can be either parallel or antiparallel. Additionally, the sheets adopt an “in register” ar-
rangement where their side chains are on top of one another along the fibril axis[1].The 
separation distance between identical side chains is 4.8 Å in parallel sheets and 9.6 Å in 
antiparallel sheets.[1] 
Short segments of amyloid-forming proteins that form microcrystals and fibers with simi-
lar morphology to the entire protein fibers have been used for the determination of the 
architecture of cross- spines.[14] These studies revealed that the amyloid protofilament 
consists of -sheets running along the length of the crystals.[1] The side chains of the 
sheets within the protofilament are tightly interdigitated resembling the teeth of a zipper. 
The steric zippers are classified according to their sheet-to-sheet arrangement: (i) face to 
face (class 1), (ii) face to back (classes 2 and 4), (iii) pack with opposite edges up (class 
4), (iv) with antiparallel strands (classes 5-8). Figure 2 shows the atomic structures of 
steric-zipper protofilaments from amyloid-forming proteins. Many proteins contain several 
steric zipper-forming segments from different classes within their primary sequences, 





Figure 1.The characteristic diffraction pattern observed for cross- structures when X-ray is 
directed on amyloid fibers. Figure taken from Eisenberg et al.[1] 
 
IDPs may enter the amyloid state when a segment has backbone amide N-H and C=O 
groups exposed, allowing their coupling into hydrogen bonds with other protein chains. 
The process of amyloid formation initiates with the lag phase. During the lag-phase, un-
folding/misfolding of the monomers generates species capable of undergoing oligomeri-
zation.[15] Three or four protein molecules expose their amyloid-forming segments form-
ing a stable oligomer nucleus which template the bonding pattern of the fiber spine.[14] 
Since formation of stable oligomeric nuclei is a thermodynamically unfavoured process, 
the lag phase is the rate-determining step of amyloid formation.[16] Taking this into ac-
count, only exposure of amyloid-forming segments is not sufficient for amyloid formation. 
The monomer concentration must be high enough to overcome the entropy against for-
mation of ordered fibers. Formation of the nucleus initiates the elongation phase, where 
monomers can join the nucleus which grows and extends at an exponential rate to fibrils. 
Moreover, breakage of the fibrils supply new fibril ends for elongation, and thus affect the 
kinetics of fibrillar growth.[1] Finally, the saturation phase is reached when the monomer 
concentration is critically low and fibril elongation is terminated (Figure 3). The rate-
limiting lag-phase can be circumvented in the pre-formed nuclei. These nuclei can act as 
fibrillar seeds that template monomer refolding and assembly into amyloid fibrils.[5, 16] 
Among all the species formed during the process of amyloid formation, the mature fibrils 
are the most thoroughly investigated species due to their high stability.[16] While fibrils 
can be identified by the above mentioned methods congo red and ThT assays, atomic 
force microscopy (AFM) and transmission electron microscopy (TEM) are the methods of 
choice for the classification of peptide self-assemblies such as oligomers, proto-fibrils 
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and amyloid fibrils consisted of varying numbers of strands and amorphous aggre-
gates.[16, 17] Secondary structure transition during amyloid formation have been monitored 
using circular dichroism (CD), fourier-transform infrared (FTIR) and nuclear magnetic 
resonance (NMR) spectroscopy.[16] However, accumulating evidence has attributed tox-
icity not to the mature fibrils but to the transient oligomers populating the lag phase. Due 
to their highly dynamic and transient nature, characterization of the toxic oligomeric spe-
cies is still challenging and, to date, the mechanism leading from monomers to aggre-
gates remains unclear. 
 
 
Figure 2. Atomic structures of steric zippers protofilaments from amyloidogenic proteins. 
Figure taken from Eisenberg et al.[1] 
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Figure 3. Amyloid formation pathway. Figure adapted from Hoffmann et al.[5] 
 
 
2.1.2 BIOLOGICAL ROLE OF HIAPP 
 
hIAPP is a 37-residue peptide and the major component in the islet amyloids in the pan-
creas (these pancreatic islets are also known as the islets of Langerhans). The peptide is 
translated as an 89-residue long pre-pro hormone and is matured along with insulin 
through the secretory pathway.[18] Cleavage of a 22-residue signal peptide and formation 
of an intramolecular disulfide bridge upon transporting the protein from the endoplasmic 
reticulum (ER) to the trans-Golgi network yields the pro-form (pro-IAPP). Pro-IAPP is 
further processed in the Golgi and insulin secretory granules. The prohormone convert-
ases PC2 and PC1/3 cleave the N- and C-terminal flanking peptides.[18] Finally, carboxy-
peptidase E catalyzes the cleavage of the dibasic residues to form a Gly, which is then 
amidated by the peptidyl amidating mono-oxygenase complex (see Figure 4).[19]  
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Figure 4. Processing of human PreProIAPP to form mature IAPP. Figure taken from Cao et 
al.[19] 
hIAPP is co-secreted with insulin from the -cells according to nutrient influx.[10, 19] Its 
physiological function is not fully understood, but the conserved sequence homology 
species imply functional significance.[10] The peptide has the function of an anorectic 
hormone in the central nervous system, reducing caloric intake, controlling gastric emp-
tying[20] and maintaining glucose homeostasis.[21] hIAPP is believed to be involved in reg-
ulating the secretion of glucagon[16, 22-24] and to play a role in regulating the glucose levels 
in blood by inhibiting insulin secretion from the pancreas.[22] 
The peptide is stored in the halo region of the insulin secretory granules while insulin is 
localized in the dense core of the granule.[19] Its small size, fast dynamics and unstable 
secondary structure are linked to its inherent tendency to aggregate into insoluble fi-
brils.[25] These aggregates are the major component of the extracellular amyloid plaques 
observed in pancreatic islets of patients with T2D[10] which is characterized by insulin 
resistance, defective insulin secretion, loss of -cell mass and -cell apoptosis.[20, 26] 
However, the hIAPP concentration in secretory vesicles is in the millimolar range and is 
much higher than the concentration required to promote rapid amyloid formation in 
vitro.[16] This suggests that a series of factors such as intragranular pH, interaction with 
insulin, interaction with metal ions and oxidative stress may play a role on inhibition or 
stimulation of hIAPP aggregation. 
Although T2D has been associated with extracellular accumulation of amyloid deposits, 
there is sufficient evidence that hIAPP aggregation starts in intracellular spaces. As pro-
IAPP was also observed in amyloid deposits[27], it is suggested that it acts as an aggre-
gation template for further hIAPP accumulation intra- and extracellularly.[20] Intracellular 
oligomerization and fibrillation are thus proposed to be the first steps of the hIAPP-
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induced cytotoxicity which is associated to disruption of the membrane integrity.[16] Three 
models for the hIAPP-mediated membrane disruption have been proposed (Figure 4): (1) 
electrostatic interaction between the cationic residues and anionic lipids lead to an in-
creased local concentration and enhanced orientation of the peptide at the interface of 
the membrane promoting initial amyloid nucleation.[28, 29] Consequently, membrane integ-
rity is disturbed by fibril growth resulting in thinning and fragmentation[30]; (2) the toxic 
oligomer hypothesis predicts structural transition of hIAPP monomers bound to the 
membrane from a disordered structured into a partially -helical conformation followed 
by oligomerization.[31] The hydrophobic on-pathway oligomers permeate the membrane 
causing membrane disorder by a detergent-like mechanism[32]; (3) in the pore theory, 
hIAPP forms non-selective ion channel-like pores resulting in insufficient homeostasis.[33] 
Therefore, membrane-mediated amyloid formation takes place intracellularly inducing -
cell death. The final deposition of amyloid plaques in the extracellular space impairs islet 
structure and function.[16] 
 
Figure 5. Mechanisms proposed for hIAPP-mediated membrane disruption. Figute Taken 
from Owen et al.[16] 
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2.1.3 STRUCTURAL CHARACTERIZATION OF HIAPP 
 
hIAPP amyloid fibrils adopt a cross- architecture commonly observed for amyloidogenic 
peptides. In hIAPP protofibrils the seven first residues may not be involved in the -
structure core due to conformational constraints imposed by the disulfide bridge.[19] The 
atomic level model proposed for hIAPP fibrils is derived from NMR studies. In this model, 
-strands are in parallel, in register arrangement. The protofibrils are composed by two 
columns of hIAPP monomers adopting a U-shaped structure. In fibrils, each monomer 
contains of two -strands connected by a loop. They encompass the residues 8-17 and 
28-37.[34] The -strands are involved in intermolecular hydrogen bonds with neighboring 
polypeptide chains within the same column but not in intramolecular hydrogen bonds.[19] 
Additionally, the residues Arg11, Ala13, and Phe15 are solvent-exposed.[19] A second 
atomic level model was proposed based on X-ray crystallographic studies of fragments 
derived from hIAPP. This model is similar to the one developed from NMR data expect 
for differences in details of the atomic packing in the monomers, differences in the bimo-
lecular interface between two hIAPP monomers, and differences in the register at the 
bimolecular interface.[19, 35] 
In both presented models, the 20–29 segment forms the partially ordered loop region 
that connects the two strands, albeit 2D IR experiments have shown that these the resi-
dues 23–27 form parallel -sheet structures in oligomeric intermediates. Further, IM-MS 
coupled to IR spectroscopy revealed that extended NFGAIL oligomers exhibit a signifi-
cant extent of -sheet conformations.[36] Based on the results obtained from two dimen-
sional IR experiments (2D-IR), Serrano et al. propose that the free energy necessary for 
disruption of the oligomeric -sheet structure and rearrangement into the structure of the 
fibril slows aggregation, lengthening the lag phase, and stabilizing the population of the 
oligomers.[37, 38] 
Like other peptides, hIAPP follows an aggregation pathway comprising a lag, a growth 
and a saturation phase. Recent time-resolved biophysical and biological studies per-
formed by Abedini et al. have proved the time-dependency of hIAPP toxicity to -cells.[4] 
In their work, aliquots of a buffered and incubated hIAPP solution were added at various 
time points over the course of the aggregation pathway and applied to -cells. Real-time 
biophysical characterization by ThT assays TEM concurrent with toxicity assessment in 
-cells revealed that a pre-amyloid lag-phase intermediates upregulate oxidative stress, 
inflammation and apoptosis.[4] Further analysis by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) of aliquots of toxic lag phase intermediates showed a 
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distribution of oligomers ranging from monomers to hexamers. The same distribution of 
hIAPP oligomers were also observed by IM-MS studies within two minutes after initiating 
amyloid formation.[39] These results reinforce previous evidences that transient soluble 
oligomers rather than mature fibrils are the cytotoxic species. However, similar distribu-
tion of oligomers of non-toxic rIAPP and other hIAPP-variants are also observed sug-
gesting that cellular toxicity rely rather on conformational properties of the transient oli-
gomers than on their size.[4. Various groups have been intensively working on the char-
acterization of these toxic intermediate oligomers that populate the lag phase and on 
disentangling the mechanism for amyloid formation.  
An important factor to be considered is the environment where the aggregation takes 
place and transfer physiological conditions into in vitro experiments. Oxidative environ-
ments have been shown to affect the kinetics of hIAPP aggregation. In cells, the redox 
state of the ER is shifted towards reducing conditions in T2D resulting in folding deficien-
cies.[40] ThT assays supported by NMR experiments showed that hIAPPred aggregates 
faster than hIAPPox. EM and solution-state heteronuclear single quantum coherence 
NMR (HSQC-NMR) experiments of hIAPP aggregates at different redox states revealed 
different morphologies of the fibrils formed by hIAPPred and hIAPPox. These results indi-
cate that aggregation shifts the equilibrium to the reduced state of the peptide. There-
fore, external factors having impact on the ER redox state could trigger hIAPP aggrega-
tion in cells.[41] 
CD spectroscopy in combination with solution-state NMR experiments on reduced and 
oxidized forms of hIAPP monomers revealed strong helical propensity for the N-terminal 
half of the peptide (residues 8–17) and a random coil conformation for the C-terminal half 
of the peptide.[41, 42] Other studies also showed that the same residues adopt a fully heli-
cal structure when bound to membrane surfaces or micelles.[42, 43] However, in compari-
son to hIAPPox, hIAPPred showed a smaller helical propensity. These results suggest that 
the disulfide bridge at the N-terminus stabilizes the helical conformation and consequent-
ly protects the peptide from aggregation.[41] Miranker and coworkers[31] also detected a 
decrease in the helical content throughout the same region when the disulfide bond is 
reduced. However, the lower extent of helices was correlated to a decrease in fibril for-
mation.[31] The structure of mature fibrils is known from solid-state NMR experiments. In 
the strand-turn-strand structure adopted by hIAPP monomers in amyloid fibrils, the N- 
and C-terminal strands involve the residues 8–17 and residues 28–37, respectively. 
Based on the structure of mature fibrils, Miranker proposed a model for oligomerization 
based on parallel helix-helix interactions.[31] The helical conformations are stabilized by 
negatively charged membranes. Their association in parallel leads to a high local con-
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centration of amyloidogenic regions in the required arrangement for -sheet formation, 
thus acting as catalyst for fibrillation.[31] 
Other hypothesis for hIAPP aggregation through -sheet conformers without involving -
helical intermediates has also been suggested. Using a combination of IM-MS and MD 
simulations, Dupius et al. proposed -hairpin as the structures of the early intermediates 
preceding hIAPP aggregation.[8] IM-MS results identified two distinct conformers for the 
triply and quadruply protonated hIAPP monomers. The compact +4 ion has a helix-coil 
type secondary structure whereas a -hairpin was assigned to the extended +4 mono-
mer. To the dominant +3 hIAPP conformer a compact -sheet-rich structure was as-
signed.[8] The hIAPP dimer was also analyzed by IM-MS.[44] The experimental collision 
cross section (CCS) for the dominant structure and the respective estimated CCS fit well, 
assuming no change in the monomer structure with dimer formation. This suggests that 
the dominant dimeric conformer assembled from the -hairpins.[44] The results published 
by the Bower’s group are consistent with previous suggestions that hIAPP populates two 
conformers, where one is more amyloidogenic than the other.[45] Moreover, identification 
of a monomeric -hairpin gives experimental evidence for the “early conformation transi-
tion” mechanism, by which nucleation starts from ordered structures and conformational 
transition from unordered to -structure occur before nucleation.[8, 46] 
As controversial as the experimental evidences published so far, theoretical work has not 
yet achieved a consensus on the structure of intermediate oligomers. REMD simulations 
performed by Reddy et al. revealed three stable conformations for the peptide in solu-
tion: an -helical conformation comprising the residues 9–17 with -sheet domain be-
tween residues 24–28 and 31–35; a -hairpin with a turn at residues between 20 and 23; 
and a random coil conformation. -helical and -hairpin structures in solution are stabi-
lized by intrapeptide hydrogen bonds and are enthalpically preferred over random coils 
which are stabilized by peptide-water hydrogen bonds.[47] Moreover, long molecular 
simulations showed that the -helical conformation can spontaneously convert into the -
hairpin. The stability of the -helical structure is believed to be affected by interaction of 
the residues 24–28 near the C-terminus with the -helical segment, leading to misfolding 
into a -hairpin. In the rat IAPP, the presence of proline residues near the C-terminus 
prevents destabilizing interactions, leading to a more stable native state.[47] 
Whereas previous MD simulations support the early conformation transition mechanism 
via the -hairpin early oligomers, recent large-scale discrete MD revealed accumulation 
of helical intermediate states before aggregation in agreement with results showed by in 
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vitro studies.[35, 41, 42] MD simulations showed that formation of hIAPP aggregates from 
monomers to hexamers is a dynamic process involving inter-exchanges between differ-
ent species.[48] These intermediates are on average composed mainly of helical confor-
mations. Similarly, the 8–20 fragment assembled into helix-rich oligomers ranging from 
dimers to decamers by shielding the hydrophobic surface of the helices.[49] In both simu-
lations, the content of -sheet conformations increased wit oligomer size accompanied 
from a decrease in coil structures while the overall helical content remained constant. 
The highest content of -sheet structures within the full-length hIAPP was found for pen-
tamers and hexamers and -sheet was the dominant secondary structure observed for 
hIAPP 8–20 oligomers higher than decamers. Analysis of secondary structure propensity 
per residue indicates high propensities to form -helices by the residues 8–15 in both 
monomers and higher order oligomers. Weakly populated -sheet structures formed by 
residues around 16–20 and 24–28 and the relatively high propensity of the residues 21–
23 to adopt turn conformations are consistent with a -hairpin structure in this region.[48]  
These simulations support an aggregation mechanism by which nucleation initiates with 
formation of helical oligomers assembled direct from isolated helical monomers. Confor-
mation transitions into -sheets occur inside the oligomers and are more significant for 
pentamers and hexamers. The last step proposed for this oligomerization process is the 
conversion of the -sheet-rich oligomers to -barrel structures, i.e. -rich oligomers in the 
shape of a barrel, which were indicated to be the toxic.[48] These toxic -barrel oligomers 
have been recently discovered in the aggregation of a fragment from the protein B-
crystalline.[50] Experimental characterization and computational modeling also indicated 
formation of -barrel by other peptides.[51] Further MD simulations on short peptides de-
rived from hIAPP and other peptides suggested that -barrel oligomers are the common 
intermediates for amyloids assembling into cross- like aggregates.[52] These structures 
have also been proposed as the toxic oligomer species since their capability of interfac-
ing across the membrane bilayer is compatible with the “amyloid-pore” hypothesis of 
amyloid toxicity.[53] 
2.1.4 INTERACTION OF AMYLOIDS WITH TRANSITION METALS 
 
The morphology of hIAPP fibrils and the kinetics of fibrillization highly depend on the en-
vironmental conditions.[54] While the hIAPP aggregates are readily observed in vitro at 
lower concentrations, the peptide is accumulated at millimolar concentration in vivo. As 
there is no difference in the amino acid sequence within the peptide in diabetic and 
nondiabetic individuals, external factors in the cellular environment might act as triggers 
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for aggregation by stabilizing the protein at high concentrations.[55] The role of metals in 
hIAPP aggregation has been increasingly explored by several groups due to its potential 
biomedical importance.[11] In particular, zinc and copper ions have been widely associat-
ed with T2D.  
The highest concentration of zinc in the body is found in the -cells, where it is stored 
with hIAPP and insulin. The high content of zinc in these cells can be explained with the 
packaging of crystalline insulin, which needs two zinc ions per insulin hexamer.[56] More-
over, the relationship between zinc deficiency in the granules and the occurrence of T2D 
have implicated that zinc ions prevent peptide aggregation as zinc supplements have 
shown to decrease -cell death.[57] In contrast, the inductive effect of zinc on hIAPP ag-
gregation has also been reported.[57] 
Despite of these numerous evidences for the importance of these metal ions in T2D, the 
exact structure of the species formed upon metal-binding as well as the mode of coordi-
nation remains elusive. Two Zn(II) coordination models have been proposed for hIAPP 
monomers, both involving the His18 residue. At physiological pH, zinc is coordinated to 
the N-terminal amine together with the imidazole nitrogen of His18 and two molecules of 
water (Fig. 6, left).[58, 59] Besides the His18, an oxygen atom of the contiguous Ser19 is 
likely to coordinate to zinc (Fig.6, right).[60] Furthermore, ESI-MS data has identified a 
small population of hIAPP monomer bound to two zinc atoms at millimolar concentra-
tions of ZnCl2, suggesting that hIAPP possess a second Zn(II) binding site with weak-
affinity.[57] This monomer bound to two zinc atoms is believed to be the key for the pro-
posed bimodal effect on hIAPP fibrillogenesis.[60] 
 
Figure 6. Two Zn(II) coordination models for hIAPP.[58] 
According to Ramamoorthy’s group, the effect of zinc ions on hIAPP aggregation de-
pends on their concentration and different stages of the aggregation process.[11] At low 
concentrations, zinc has an inhibitory effect on fibril formation by increasing the lag time. 
This hypothesis suggests that zinc ions stabilize the prefibrillar aggregates, thus prevent-
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ing equilibrium towards mature fibrils.[61] More specifically, zinc forms very stable off-
pathway hexameric species with hIAPP while inhibiting the formation of the dimer. The 
presence of Zn(II)-bound hexamers at low zinc concentrations were confirmed by MD 
simulations.[62] The electrostatic repulsion of adjacent -sheets in presence of zinc is also 
proposed to modulate inhibition.[60] At higher concentrations zinc ions show an opposite 
effect where they promote the formation of aggregates.[57, 60] In contrast, AFM studies 
have reported a reverse behavior, i.e. inhibition of aggregation at higher zinc concentra-
tions.[56] These contrasts rely on the hIAPP concentration, which has to be sufficiently 
high to lead formation of high-molecular weight oligomers.[62] 
It is important to keep in mind that amyloidogenic peptides exist in a highly dynamic equi-
librium between transient species and each oligomer may have different affinities for 
metal ions. IM-MS has been used in order to investigate which transient species show 
higher affinity to metal ions and to estimate the conformation of the metal-associated 
oligomers. Bowers et al. have identified two conformers for the Zn(II)-hIAPP monomers 
with charge state +4. The abundance of the extended hIAPP monomer in the presence 
of zinc was higher in comparison to metal-free hIAPP. Based on these results, Bowers et 
al. suggest that higher zinc concentrations stabilize the extended -hairpin hIAPP con-
former, which then becomes less amyloidogenic.[56] 
 
Figure 7. Two Cu(II) coordination models for hIAPP.[58] 
The elevated copper levels in serum observed in T2D also suggest a direct relationship 
between copper ions and hIAPP aggregation. The role of copper-complexation on hIAPP 
aggregation is equally discussed in recent literature. Several studies have shown an in-
crease in production and accumulation of toxic hydrogen peroxide in the presence of 
Cu(II) in vitro.[63] However, generation of specific oligomeric species, rather than produc-
tion of hydrogen peroxide has been proposed to be crucial for cytotoxicity of hIAPP in the 
presence of copper.[64] 
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Similar to Zn(II), a consensus on the coordination mode of Cu(II) to hIAPP monomers 
has not yet been reached. Riba et al. proposed that Ala25 and a second residue near the 
C-terminus are the possible binding sites for copper ions in full-length hIAPP.[65] Howev-
er, a variety of experimental and theoretical approaches support that the residues 18–25 
are responsible for metal coordination within hIAPP.[57, 66-68] In the proposed models, the 
anchoring role played by His18 is undeniable.[58] The two amide groups adjacent to the 
His establish the coordination towards the C- or N-terminal region.[58] Based on spectros-
copy and computational studies, Quintanar’s group has proposed an equatorial binding 
motif towards the C-terminus at physiological pH, where the copper ion is complexed to 
three nitrogen atoms and one oxygen atom (3N1O).[66] In this model, copper is coordi-
nated with the imidazole nitrogen of His18 and two deprotonated nitrogen amides of the 
Ser19 and Ser20 residues. The Ser20, furthermore, coordinates to the copper with an 
oxygen atom either from the alcohol side chain or from the carbonyl group.[66] In the 
model proposed by Magrí et al., apart from His18, three deprotonated amides are in-
volved, forcing the coordination toward the N-terminus.[69]  
While the role of zinc on amylin aggregation is more complex and still a matter of debate, 
the inhibition of fibril formation by copper is more widely accepted. It was suggested that 
the presence of Cu(II) increases the barrier for oligomerization, thereby extending the lag 
phase and slowing down the rate of aggregation.[11] Using mass spectrometry, Li et al. 
showed that Cu(II) inhibits fibril formation by preventing formation of hIAPP dimers.[70] 
Further evidence is provided by CD spectroscopy and TEM experiments. Lee and 
coworkers have shown that the secondary structure of hIAPP in the presence of copper 
ions is mainly random coil. They also reported formation of small and globular non-
fibrillar Cu(II)-hIAPP aggregates with distinct morphologies from those formed by Zn(II)-
hIAPP and metal-free hIAPP. 
Lee et al. also performed ion mobility studies on zinc-bound hIAPP and compared the 
results to copper-bound hIAPP. Based on IM-MS experiments and MD simulations, they 
reported the higher affinity of Cu(II) for the compact conformation. According to Lee et 
al., these differences rely on local changes around His18.[67] The Cu(II)-hIAPP in solution 
has a maximum charge of +3. Even in the gas phase, the Cu(II)-coordinated region re-
mains as +1 charge state as in metal-free hIAPP. In the case of Zn(II)-hIAPP, formation 
of the +4 ion involves protonation of two possible sites. Due to the distribution of positive 
charges, the local structure around His18 is rearranged to accommodate the zinc ion. 
The differences in the coordination chemistry of zinc and copper ions toward amylin have 
been pointed as one of the reasons leading to distinct aggregation pathways of metal-
coordinated hIAPP.[67] 
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2.2 TECHNIQUES AND METHODS 
2.2.1 ION MOBILITY-MASS SPECTROMETRY  
 
Gas-phase techniques offer a good alternative to condensed-phase analytical tech-
niques to provide structural information on isolated species derived from a complex en-
semble. Especially IM-MS has been employed in the analysis and characterization of 
isolated molecules in the presence of other species. As a separation technique, IM-MS 
has been extensively applied in structural biology. In the field of amyloid research, spe-
cies with the same m/z-ratio can derive from different homo-oligomers. With ion-mobility 
separation prior to m/z-selection, individual conformers of an assembly can be investi-
gated individually.  
The basic principle of ion mobility spectrometry (IMS) is based on the characteristic mo-
bility of ions, or the ability of ions to move through a certain medium, which depends on 
their shape, charge and mass. Ions are guided through a cell that is filled with an inert 
neutral buffer gas such as helium or nitrogen, under the influence of a weak electric field. 
During their trajectory, the ions suffer more or less number of collisions with gas mole-
cules according to their size, shape and charge. Compact ions are more mobile and 
therefore pass through the cell faster than more extended ions. Multiply charged ions 
have a higher mobility than singly charged ions of same m/z. In this way, ions of the 
same m/z-ratio and different conformations can be separated within the mobility cell. 
Thus, while MS determines the m/z-ratio of an analyte ion, IMS separates them based 
on their size and shape. The recorded drift time can be converted into a collision cross 
section (CCS), which is an intrinsic property depending on the ion’s overall structure and 
also independent of the utilized instrument parameters and conditions. 
 
Figure 8.  Scheme of an ion mobility separation. In this figure, separation based on the shape 




2.2.2 COLLISION CROSS-SECTION CALCULATION  
 
The collision cross section (CCS) is an intrinsic property of a molecule and is related to 
its shape. Under controlled conditions, the CCS value is independent of instrument pa-
rameters, enabling the creation of databases. In order to experimentally determine the 
CCS, all the instrument parameters and settings must be accurately known. The drift 
velocity ν of the ion is the product of ion mobility constant K and the electric field E,  
𝑣 = 𝐾 ∗ 𝐸 = 𝐾
𝑉
𝐿
     (1) 
The velocity is determined by measuring the time the ions require to traverse the drift 
cell, tD and it is proportional to the inverse mobility (1/K) as well as the inverse of the 
electric field (1/E). Therefore, the mobility of an ion can be determined from the slope of 
a plot with tD versus 1/Vd, where Vd corresponds to the drift voltage. The intercept, t0, 








+ 𝑡0    (2) 
In low-field conditions, the velocity of the ion is directly proportional to the electric field by 
the proportionality ion mobility constant K and is related to the ion’s collision cross-
section (Ω) by the Mason-Schamp-equation[9] (Equation 3.3)  








     (3) 
where z* e is the ionic charge, N the drift gas number density, μ the reduced mass of the 
ion and the drift gas, kB the Boltzmann constant, and K0 the reduced ion mobility (Equa-
tion 2).[9] When coupled to mass spectrometry, the mass and charge are known and the 
CCS can be calculated.  
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Figure 9. Determination of the mobility of an ion. The measured drift times are plotted 
against the invert of the drift voltages. The intercept, t0 gives the dead time and the slope the 
mobility K. 
2.2.3 INFRARED SPECTROSCOPY 
 
An IR spectrum results from transitions between quantized vibrational states when a 
molecule absorbs resonant IR light. Nonlinear molecules with N atoms have 3N degrees 
of freedom. Three of them represent translational motion and three represent rotational 
motion about the x, y and z axes. The remaining 3N-6 degrees of freedom refer to the 
vibrational modes. Because rotation of a linear molecule about its axis does not lead to 
displacement of the atoms, linear molecules lose one of the rotational degrees of free-
dom and have an additional vibrational mode. Thus, the number of vibrational modes of 
a linear molecule is 3N-5.[71] For each vibrational mode all atoms vibrate at a certain fre-
quency, i. Atoms vibrating with harmonic motion (i.e. obeying Hooke’s law) have an 
harmonic potential well as depicted by the dashed lines in Figure 10. 
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Figure 10.  Harmonic (dashed line) and Morse-potential (solid line) of a diatomic molecul as 
a function of the atomic displacement during vibration.[71] 
The vibrational energy states for modes in which atoms have a harmonic motion can be 
described by the equation 
𝑉𝑖𝜐 = ℎ𝜈𝑖 (𝜐𝑖 +
1
2
)     (4) 
where h is Planck’s constant, i the vibrational quantum number of the i-th mode and i 
the vibrational frequency given in units of wavenumber (cm-1). Vibrational transitions oc-
cur only if the dipole moment of the molecule, , changes during the vibration, i.e., where 
Qi are normal coordinates used to describe the vibrational motion of the atoms.  Depend-
ing on the element of symmetry that a molecule has, some vibrational modes may be 
degenerate. As a consequence, more than one mode has a given vibrational frequency 
whereas others may be completely forbidden and the number of fundamental absorption 
bands is usually less then 3N-6.[71] 
However, molecular vibrations deviate are anharmonic and the variation of the potential 
energy as a function of the displacement of atoms from their equilibrium positions are 
described by an anharmonic Morse-potential (represented by the solid line in Figure 10) 
and is given by the expression  
𝑉𝑖𝜐 = ℎ𝜈𝑖 (𝜐𝑖 +
1
2





    (5) 
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where xi is the anharmonicity constant. In the harmonic picture no transitions where Δi ≥ 
±1 would be allowed. The anharmonicity relaxes this selection rule, and therefore, weak 
overtone and combination bands can be observed in the mid-infrared spectrum along 
with fundamental bands.  
Many vibrational modes have a frequency that is characteristic for certain functional 
groups and is barely affected by the environment within the molecule. Other bands occur 
at frequencies that vary from a molecule to another containing a particular functional 
group. These bands are known as fingerprint bands and their vibrational frequencies are 
influenced by intra- and intermolecular effects.[72] 
In protein analysis, five typical bands can be observed in an IR spectrum due to absorp-
tion of protein backbone. These bands derive from the normal modes of the amide 
group. Amide A and B bands occur at wavenumbers above 3000 cm-1 and correspond to 
the N-H stretching vibrations. The amide I band between 1600 and 1700 cm-1 has the 
strongest absorption of IR light and is caused by C=O stretching vibration with minor 
contributions with the out-of-phase C-N stretch and N-H bending. The amide II band at 
1500-1600 cm-1 arises mainly from the out-of-phase combination of the NH in plane bend 
with the CN stretching vibration. Lastly, the amide III band, found in the 100-1400 cm-1 
region, is derived from the in-phase combination of NH bending and CN stretching along 
with deformation vibrations of CH and NH. The amide I band is highly sensitive to the 
secondary structure of proteins and peptides and is used to obtain structural information 
from the spectral features.[72] 
 
2.2.4 ATTENUATED TOTAL REFLECTION–FOURIER TRANSFORM INFRA-RED SPECTROS-
COPY 
 
Infrared spectroscopy consists is one of the classical methods of structure determination 
of small molecules and has been shown to be a powerful tool for gaining insight into pro-
tein structure.[72] The two most traditional methods are transmission and attenuated total 
reflection (ATR) spectroscopy. In transmission measurements, IR light is passed through 
a cuvette containing the sample before it reaches the detector. The sample absorbs the 
light according to the Lambert-Beer law[71]: 
𝐼(𝑣) = 𝐼0𝑒
−𝜎(𝑣)𝑙𝑛    (6) 
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In the ATR technique the sample is placed in contact with an infrared transparent surface 
with a high refractive index called internal reflection element (IRE). IR light is directed at 
the interface between the sample and the IRE. When the angle of incidence is greater 
than the critical angle, the incident IR light is totally reflected.[72, 73] Despite of the sample 
being confined to the IRE, the electromagnetic field of a photon is oriented perpendicu-
larly to its path. This electromagnetic field is also referred as evanescent wave. At the 
point of the contact between the sample and the IRE, the field extends from the interface 
into the sample and decays exponentially with the distance from the surface. The 
strength of the electrical field, E, can be written as a function of the distance z from the 
surface 
𝐸 = 𝐸0𝑒
−𝛾𝑧     (7) 
where E0 is the strength of the electrical field at the surface. The distance from the sur-
face where the evanescent wave still interacts with the sample can be approximated as 
the distance from the surface at which the intensity of E has attenuated to 1/e of its initial 
intensity E0. This distance is called depth of penetration, dp, corresponds to 1/𝛾 from the 
equation 3.5. and it is depends directly on the wavelength of the incident radiation, 𝜆, the 
angle of incidence 𝜃 and the relative refractive index of the sample and IRE (n2/n1).
[72-74] 










    (8) 
 
Modern spectrometers used in routine measurements are usually Fourier transform infra-
red (FTIR) spectrometers. The heart of any FTIR spectrometer is an interferometer.[72. 
Figure 11 depicts the commonly used Michelson interferometer. It consists of a fixed and 
a movable mirror and a beam splitter. Light emitted from the light source reaches the 
beam splitter. Half of the emitted light is reflected towards the fixed mirror and then re-
flected back towards the beam splitter where approximately 50% traverses to reach the 
detector. The other half of the emitted light passes the beam splitter and reaches the 
movable mirror. There it is reflected back to the beam splitter where 50% of the light is 
reflected towards the detector. The two beam combines, leading to constructive or de-
structive interference depending on their difference in the travelled path. The light inten-
sity as a function of the position of the movable mirror is measured. The resulting inter-
ferogram corresponds to a Fourier transform of the spectrum. The computer performs a 
second Fourier transform converting the measured data back into a spectrum.[72] 
 22 
  
Figure 11. Sketch of a Michelson Interferometer.[73] 
 
 
2.2.5 ACTION SPECTROSCOPY  
 
When performing spectroscopy in the gas-phase, samples are optically diluted and direct 
absorption IR spectroscopy techniques cannot be applied in this case. In Eq. 3.6, the 
product of number density and optical path length is typically so small that the difference 
between I() and I0 is not measurable. Alternatively, action spectroscopy methods moni-
tor the effect of IR radiation on molecules. Such effects include changes in ionization 
yield, quantum state, fluorescence yield, fragmentation or electron detachment.[75] The 
number of molecules affected by the IR radiation can be expressed by: 
𝑁(𝜈) = 𝑁0𝑒
−𝜎(𝜈)Φ(𝜈)     (9) 
where Φ(𝜈)is the photon fluence. However, large systems such as covalently bound 
molecules or noncovalent and very stable complexes have a very high threshold to dis-
sociation which is much higher than the energy of a single IR photon. Therefore, absorp-
tion of multiple photons by a single ion is needed to induce dissociation. This experi-
mental method is named infrared multiple photon dissociation spectroscopy (IRMPD) 
and in this approach a high flux of photons is required, which is achieved with the use of 




2.2.6 INFRARED MULTIPLE PHOTON DISSOCIATION 
 
IRMPD is an activation method used in gas-phase spectroscopy based on the sequential 
absorption of multiple photons. When the radiation frequency is resonant with the vibra-
tional transitions of a molecule, photons are absorbed leading to an increase in its inter-
nal energy. However, in the here considered process, the multiple photon excitation is 
not a process where the absorption of photons from a monochromatic laser source oc-
curs in one vibrational ladder in a stepwise manner (=0  =1…). This lies on the fact 
that molecular vibrational potentials are inherently anharmonic. In the anharmonic picture 
of the vibrational potential, the spacing between adjacent vibrational levels decreases as 
the vibrational quantum number increases. This effect is commonly referred as anhar-
monicity bottleneck.[75, 76] 
The anharmonicity introduces terms in the potential that lead to coupling between normal 
modes. Due to this coupling, energy flux from a vibrational mode into another is possible, 
so that an excited vibrational level can be deactivated by intramolecular vibrational redis-
tribution (IVR).[76]Therefore, another photon can be absorbed as soon as the fundamen-
tal vibrational level is deactivated. The efficiency of the multiple photon excitation (MPE) 
depends largely on the rate of the IVR process, which for polyatomic molecules at room 
temperatures, occurs in sub-ns timescale. As a consequence of the sequential multiple 
photon absorption and subsequent depletion of the excited vibrational mode, the vibra-
tional excitation is randomized over the entire molecule leading to an increase in its in-
ternal energy. When the threshold is achieved, usually the weakest bond breaks.[75, 76] 
The Figure 12 depicts the IRMPD fragment spectra of the polyalanine peptide used in 
this thesis. The absorption of resonant light induces fragmentation of the parent ion gen-
erating b and y-type fragments. IR spectrum is then obtained from the intensities of the 








Free-Electron Laser (FEL) 
 
The experimental methods in the gas-phase described in the previous sections rely on 
the use of tunable IR laser sources capable of providing a high photon flux. This is 
achieved by the use free-electron lasers (FEL).  
In the FHI-FEL, electrons provided by an electron gun are accelerated close to the speed 
of light by two consecutive linear accelerators (linac). The relativistic electrons are then 
injected into the resonator, which consist in two highly-reflective mirrors positioned at 
each end of an undulator. The undulator is a periodic magnetic device that forces elec-
trons into an oscillatory motion. There, the produced radiation is captured in a laser cavi-
ty, where the circulating light pulses interact with further electron bunches, thus increas-
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ing the intensity of the radiation by 106–108 magnitudes of order. For coherent radiation 
to be produced, the wavelength has to correspond to an integer of the pathlength differ-
ence over one undulator period. Since this gap is tunable, radiation with different wave-
lengths can be emitted. A schematic depiction of the FHI-FEL used in here presented 
experiments is given in Figure 13. This FEL facility provides intense and tunable light in 
the regime of 3 to 50 M. 
 
Figure 13.  Schematic setup of the Fritz Haber Institut free-electron laser (FHI-FEL). The 
FIR/THz undulator will be built in the future. 
 
3. EXPERIMENTAL SECTION 
 
3.1 Sample Preparation 
The peptides VEALYL, human and rat islet polypeptide (IAPP), all with C-terminal amide 
were purchased from GenScript Biotech Corporation. The peptides Protegrin-1 (PG-1) 
and a fragment of the prion peptide (PrP106–126) were purchased from Anaspec. Polya-
lanine and the peptide tendamistat were provided by the group. Peptide samples were 
used without further purification. hIAPP, rIAPP, PrP106–126 and PG-1 were dissolved in 
100% 1,1,1,3,3,3-hexafluoro-2-isopropanol (HFIP) to a concentration of 500 M and ali-
quots of 20 L were taken and dried overnight. The peptides were freshly dissolved at 
different concentrations prior each experiment. All other standard chemicals and solvents  




Polyalanine was dissolved in H2O with formic acid (FA) (50%) to a concentration of 500 
M. For ATR-FTIR experiments, the sample was dissolved in 2H2O to a concentration of 
5 mg mL-1. 
Tendamistat was dissolved in NH4AcO (5mM, pH 7) with 0,1% FA to a final concentra-
tion of 100 M. To perform IRMPD spectroscopy of tendamistat-crown ether adducts, 
tendamistat was dissolved in H2O:MeOH (1:1, v/v) to a final concentration of 100 M with 
500 M of 18-crown-6. For ATR-FTIR experiments, the sample was dissolved in 2H2O to 
a concentration of 7,5 mg mL-1. 
PG-1 were resuspended for IM-MS experiments in H2O:MeOH (1:1, v/v) to a final con-
centration of 50 M. Reduction of the disulfide bond was performed by adding 2-
mercaptoethanol (10%, v/v) to the sample. For IRMPD spectroscopy of PG-1-crown 
ether adducts, a stock solution of dibenzo-30-crown-10 (db30c10) was prepared in 
H2O:ACN (1:1, v/v) and added to the fresh peptide solution of 50 M with same solvent 
conditions to yield a DB30C10/PG-1 solution of 10:1. For IRMPD experiments of PG-1 
oligomers, the peptide was diluted to 200 M in H2O:MeOH (1:1, v/v). 
Human Islet Amyloid Polypeptide 
For IM-MS and IRMPD experiments, dry hIAPP and rIAPP were resuspended in 
NH4AcO (5 mM, pH 7):MeOH (1:1, v/v) to a final concentration of 50 M. For solution-
phase IR measurements, samples were redisolved in 2H2O to a final concentration of 7.5 
mg mL-1. 
hIAPP-metal adducts 
A stock solution of 10 mM of zinc chloride (ZnCl2) and copper chloride (CuCl2) was pre-
pared. Prior to the measurements, the peptides were diluted in H2O to yield a concentra-
tion of 50 M for the respective peptide and and 500 M for the respective metal salt.  
Heterodimers 
Dry PrP106–126 was dissolved in H2O:MeOH (1:1, v/v) to a final concentration of 50 M 
and subsequently added to the hIAPP and rIAPP solutions with same solvents to yield a 
25 M: 25 M solution. 
A stock solution of 500 M VEALYL was prepared in H2O and added to a hIAPP solution 




For measuring the solution-phase IR spectroscopy, the BioATR- FTIR instrument from 
Bruker Optik (Ettlingen, Germany) was used. The spectrometer is equipped with a multi-
reflection ATR cell and a photovoltaic LN-MCT detector. The circular sampling area con-
sists of an ATR-crystal made of silicon and has a radius of 2mm. The experimental pa-
rameters are given in Table 1. 
Table 1. Typical parameters for ATR-FTIR. 
Experimental Settings 
Spectrometer Aperture 1 mm 
Resolution 2 cm-1 
Number of Background Scans 100 scans 
Number of Scans: 100 scans 
Source MIR 
Detector LN-MCT 




In order to obtain information on the secondary structure of oligomeric species, ion- mo-
bility spectrometry, mass spectrometry and infrared spectroscopy are combined in a sin-
gle experimental set-up. The drift tube-ion mobility (DT-IM) experiment (see Figure 14) 
was designed and built at the department of Molecular Physics at the Fritz Haber Insti-
tute of the Max Planck Society in Berlin. 
In the experimental set-up, the sample is transferred into the gas phase by nano-
electrospray ionization source (nESI) using borosilicate capillaries coated with Pt/Pd. 
This is an appropriate technique for the ionization in biomolecules because it allows di-
rect transfer of fragile macromolecules into the gas phase with minimal impact on the 
native, solution-phase structure.[8]The generated ions are subsequently collected in the 
entrance funnel that is operated with radio frequency (RF). In the entrance funnel, ions 
are radially collimated, trapped for a time interval on the millisecond scale and then in-
jected into the mobility cell (drift tube), where ion mobility separation takes place. Ions 
travel through the mobility cell under the influence of a weak, homogeneous electric field. 
A second funnel (exit funnel) is positioned at the exit of the mobility cell to focus the dif-
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fusionally scattered ions. Two ring ion guides then lead the ions to the high-vacuum 
stages with a quadrupole mass filter followed by a second quadrupole of identical di-
mensions. 
Two different detectors can be used according to the purpose of the experiment. When 
leaving the second quadrupole, ions can be pulsed perpendicularly towards the "time-of-
flight" (TOF) mass analyzer for acquisition of the mass spectrum, or be detected directly 
by the linearly positioned detector in order to record the time the ions take to cross the 
cell (arrival time distributions, ATD). 
To perform IRMPD spectroscopy on conformer and m/z-selected species, conformers of 
a given mobility can be selected by means of electrostatic deflection after the drift tube 
so that only ions within a narrow range of drift time are allowed to enter the mass filter 
where the m/z-selection takes place. Isolated species are irradiated with infrared radia-
tion provided by a high coherent light source, the in-house free-electron laser (FEL). Mul-
tiple photons are absorbed inducing subsequent fragmentation, which is detected with 
the TOF analyzer. The IRMPD spectrum is obtained by recording the fragmentation yield 
as a function of the wavelength in the infrared range, as previously described in section 
2.2.6. The typical experimental parameters used in this thesis are listed in Table 2. All 
the parameters were optimized in each experiment in order to obtain a good signal for 
the investigated species. 
All spectra were scanned twice from 1400 to 1800 cm-1 and averaged. The measure-
ments were carried out using different laser power settings. The term “high” laser power 
settings refers to more focused conditions and 100% attenuation, assuming that radia-
tion with approximately 100 mJ energy is produced. “Low” laser power settings refer to 
less focused conditions and less attenuation.  
Table 2. Typical parameters for DT-IM. 
Drift pressure (He)  3–5 mbar 
Electric field inside of the DT 
(V/cm) 
10–20 V/cm 
Temperature  20–25 °C 
Needle voltage 0,5–1,2 kV 
Injection voltage 30–150 V 
Drift voltages 850-1200 V 
RF entrance funnel 300–700 kHz 




Figure 14. Schematic representation of the home-built Drift Tube-Ion Mobility spectrometer 
(DT-IM-MS). 
 
3.4 Fitting Procedure of the IRMPD Spectra 
 
Three distinct methods were used in this thesis to evaluate the amide I band. The posi-
tion of the absorption bands are determined by its center at the full width half maximum 
(FWHM) as depicted in Figure 15 for an individual scan of one hIAPP conformer. When 
the amide I band has a reproducible shape, i.e. similar shapes are observed over a se-
ries of measurements and with different instrument conditions, the position at the maxi-
mum intensity is determined “by eye” as a particular feature of the band.  
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Figure 15. Determination of the center position of the amide I band. 
When applicable, deconvolution of the amide I band were performed in order to estimate 
the -sheet content within the peptide as commonly applied in condensed phase. How-
ever, gas-phase IR spectroscopy is governed by the more complicated IRMPD process 
and the resulting IR intensity is not a direct function of the number of absorbed photons. 
The content of -sheet motifs contributing to the spectral band can still be derived from 
the deconvolution of the IRMPD spectrum. In this procedure, the spectral features are fit 








]𝑛     (10) 
 
where the parameters 𝑥𝑐(𝑛),  𝜎(𝑛), and 𝐴(𝑛)denote the peak center, peak width and 
area of the n-th Gaussian, respectively. The amide I features at 1600-1700 cm-1 are fitted 
with six Gaussians using the constraints in the peak center and width shown in Table 3. 
The Gaussian at 1560–1600 cm-1 (n=0) is used to correct the baseline below 1600 cm-1. 
The fraction of -sheet signature, F() is determined from the areas of the Gaussians 
according to equation 3.11, where A(n) is the area of the n-th Gaussian. The A(6) is tak-
en into account only for antiparallel -sheet-containing peptides whereas for parallel -




      (11) 
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Table 3. Constraints in the peak center and width for the fitting amide I with multiple Gauss-
ians. 
n Peak center Peak width () 
0 1560–1600 cm-1 0–30 cm-1 
1 1600–1630 cm-1 0–30 cm-1 
2 1620–1640 cm-1 0–30 cm-1 
3 1640–1660 cm-1 0–30 cm-1 
4 1650–1680 cm-1 0–30 cm-1 
5 1660–1690 cm-1 0–30 cm-1 
6 1680–1710 cm-1 0–30 cm-1 
 
3.5 Data Analysis 
 
Analyzis of the obtained raw data (drift times, FT-IR and IRMPD spectra) and calculation 
of the collision cross-sections (CCSs) were performed using the program Origin Pro 
2016 (OriginLab Corporation, Northampton, MA, U.S.A.). Data and schemes were de-
picted with Adobe Illustrator CS6 (Adobe Systems  GmbH, München, Germany). All the 
IRMPD spectra were wavelength calibrated and power corrected. 
4.  RESULTS AND DISCUSSION 
 
4.1 Model Peptides 
Infrared spectroscopy has been shown to be a powerful tool to provide structural infor-
mation of peptides and proteins. A suitable vibration to investigate the secondary struc-
ture of these biopolymers is the so called amide I band. The oscillation is related to the 
stretching vibration of the C=O bond present in the peptide backbone. The position of the 
amide I is hardly affected by amino acid side chains but is highly sensitive to the intramo-
lecular hydrogen bonding pattern and that is specific to the secondary structure.[72] Since 
shifts in the position of the amide I are an indicative of structure transitions, IR spectros-
copy can be used to probe the structure of the intermediary oligomeric species of amy-
loidogenic peptides as well as follow the process of amyloid formation. To interpret the 
experimental data, IR spectra of so called model molecules can be used to compare the 
position of vibrational bands. These models should have a well-defined and also well-
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studied secondary structure. In condensed phase, IR spectra of various model peptides 
are readily available. In the gas phase, however, the availability of IR spectra of compa-
rable molecules is limited. Nevertheless, the position of IR bands should not be strongly 
shifted and it is common to reference the position of IR bands in the condensed phase.  
To find suitable candidates for model peptides in the gas phase, three peptides were 
chosen according to their structures determined by other analytical techniques. The IR 
spectra of m/z- and conformer-selected species were measured and compared with the 
spectra in solution-phase. A alanine based peptide serves as a model for helical struc-
tures. The pepetide tendamistat and the structurally restrained peptide protegrin were 





The strong -helix forming character of alanine amino acids and the ability of long-chain 
polyalanine peptides to form -helices in solution at physiological conditions have been 
already reported from studies based on condensed-phase techniques.[77-79] Theoretical 
studies and experiments performed in the gas phase showed that an -helix is the pre-
ferred structure of polyalanine carrying a Lys residue at the C-terminus.[78-80] Within this 
thesis, ion mobility and IRMPD spectroscopy experiments of the 20-residue peptide Ac-
Ala19-Lys-OH are performed. IRMPD spectrum of Ac-Ala19-Lys-OH has been previously 
measured using a different experimental set-up. For further information on IRMPD spec-
troscopy of alanine based peptides, the reader is kindly referred to Schubert’s work.[80] 
The investigated peptide is capped at the N-terminus with an acetyl group to avoid pro-
tonation at this site. The mass spectrum and the ATDs are shown in Figure 16. The 
mass spectrum shows the singly charged monomer whose protonation site is likely the 
sidechain amino group of lysine.[78] 
The singly and double charged monomers have very similar collision cross sections of 
374 and 364 Å2 respectively suggesting the same overall structure for both ions. The 
measured CCS values are also in agreement with the cross sections obtained for the 
same peptide previously reported by Jarrold and coworkers, who assigned helical struc-
tures for these alanine-based peptides in the gas-phase.[79] 
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Figure 16. ATDs of singly and doubly charged Ac-Ala19-Lys-H monomers. 
The m/z- and conformer-selected singly charged monomer was further interrogated with 
laser light. The absorption of resonant light lead to fragmentation of the peptide, produc-
ing b and y fragments. The resulting IRMPD spectrum is shown in Figure 11 (Section 
2.2.6). The narrow amide I band centered at 1667 cm-1 indicates that Ac-A19-KH
+ ion 
adopts a helical conformation in vacuum, as also predicted by theoretical calculations.[79, 
81] According to Jarrold, the helix is stabilized in vacuum mainly by two factors: an opti-
mized hydrogen bonding and the interaction of the charge with the helix dipole.[78] 
 
Figure 17. Gas-phase infrared spectrum of the conformer-selected Ac-Ala19-KH+ ion. The 
region colored in pink demarcates the typical absorption region for -helix secondary struc-
ture. 
To investigate and compare the secondary structure in solution, the IR spectrum of the 
peptide dissolved in 2H2O to a final concentration of 7,5 mg mL
-1 was measured with a 
commercial ATR-FT-IR spectrometer The spectrum in the range of 1550 to 1750 cm-1 
(Figure 18) shows the amide I band positioned at 1674cm-1. A shift in the position of the 
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amide I band with relation to the gas-phase spectrum is yet expected since condensed-
phase and solvent-depleted environments provide different levels of perturbations for the 
C=O oscillators. Nevertheless, the positions of the amide I bands in the gas phase and 
condensed phase are comparable. 
The ion mobility and spectroscopic results presented here, together with previous pub-
lished theoretical and experimental work[78-80] supports the choice of the polyalanine-
based peptide Ac-Ala19-Lys-OH as a model peptide for -helix structures in the gas-
phase. 
.  




The first candidate for the investigation of a -sheet containing pepetide in the gas-phase 
is the -amylase inhibitor peptide tendamistat. Tendamistat consists of 74 amino acid 
residues (7958 amu) containing two disulfide bridges between the Cys11-Cys27 and 
Cys45-Cys73. It is known for its tight binding to mammalian enzyme -amylase.[82] Its sec-
ondary structure in solution previously determined by NMR contains two three-stranded 
antiparallel -sheets interconnected by loops and irregular structure.[83] Its large propen-
sity for -sheet conformations and the absence of -helical structures in the condensed 
phase make tendamistat an attractive model peptide to indicate -sheet secondary struc-
ture of size- and m/z-selected species.  
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In order to perform IRMPD spectroscopy, fragments of the investigated molecule have to 
be easily generated upon absorption of multiple photons provided by an intense IR laser 
light source. Because of the relative high stability of large peptides, their complexation 
with other molecules can produce known fragmentation channels obtained with absorp-
tion of less photons, which can be used to obtain a good quality IRMPD spectrum. 
Crown ethers were reported to be a useful tool in charged amino acids recognition in 
gas-phase.[84] Here, we use the 18-crown-6 (18c6) complexation ability with protonated 
lysine side chains to measure an IRMPD spectrum. The Figure 19 shows the ATDs of 
the quadruply and quintuply charged ions. The +4 ion has a CCS of 904 Å2 whereas two 
conformers were fitted in the broad ATD of the +5 ion with 913 and 970 Å2.  
 
 
Figure 19.  ATDs of monomeric tendamistat ions. 
The bare +5 ion was selected to perform IRMPD spectroscopy due to the insufficient 
signal of the ion complexed with 18c6 molecule. The IRMPD spectrum of the 5+ ion fea-
tures a symmetric amide I band centered at 1665 cm-1, a typical region for -helical and 
turn-like structures. This could be associated to the loss of the -sheet structure during 
transfer from solution into the gas-phase as a result of Coulomb repulsion and intramo-
lecular self-solvation disrupting the hydrogen network.[84] In addition, the broader and 
asymmetric amide I band for the +4 tendamistat-18c6 complex displays a high intensity 
around 1640 cm-1 which could indicate some content of -sheet motif. The +4 ion experi-
ences less Coulomb repulsion and its native-like structure could be stabilized by its co-
ordination to the crown-ether molecule which caps the protonated lysine side chain 
avoiding its collapse onto the protein backbone.[84] 
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Figure 20. IRMPD spectra of m/z- and conformer-selected tendamistat ions. The regions 
colored in blue and pink demarcate the typical absorption regions for -sheet and -helix 
secondary structures, respectively.  
  
In order to compare the structure of tendamistat in vacuum and in the condensed phase, 
the IR spectrum was acquired in 2H2O in a concentration of 7,5 mg mL
-1 with the ATR-
FTIR instrument. The solution-phase structure of tendamistat has previously been re-
ported to adopt mostly a -sheet motif.[83, 85] The spectrum shown in Figure 21 displays a 
maximum absorption at 1639 cm-1 and a shoulder around 1675 cm-1, both referred to as 
an indicative of -sheet conformation. Moreover, the narrow band located at 1515 cm-1 
can be attributed to the C-C stretching vibration of the aromatic ring of tyrosine side 
chains.[85] The absence of any features which could be assigned to -helical or unor-
dered structures also confirms that tendamistat adopts mainly a -sheet motif in solution. 
However, since the monomers do not show a -sheet signature in the gas phase, ten-
damistat cannot serve as a proper model here. 
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Figure 21. ATR-FTIR spectrum of tendamistat solution. 
   
4.1.3 PROTEGRIN 
 
Protegrins are small cysteine-rich antimicrobial peptides (AMPs) that contain 16-18 ami-
no acid residues and possess a strong antibiotic activity. Their cytotoxic activity on cell 
membranes lies on the presence of positively charged amino acid residues which strong-
ly interact with the negatively charged lipid headgroups of the outer leaflets of bacterial 
cell membranes.[86] The short peptide Progetrin-1 (PG-1) is composed of 18 amino acid 
residues and is one of the five native isomers known which were first isolated from por-
cine leukocyte cells.[87] Six positively charged arginine residues contribute to its antibiotic 
effect favoring the interaction with bacterial membranes.[88, 89] Four cysteine residues, 
form two intramolecular disulfide bonds at 6Cys-15Cys and 8Cys-13Cys positions that hold 
the peptide in a -hairpin-like structure. More recently, MD simulations and AFM studies 
have shown that PG-1 has a similar behavior as the amyloidogenic A peptides in solu-
tion and on lipid bilayers.[86, 90] On the anionic surface of lipid bilayers, PG-1 was reported 
to form ion channels with -sheet subunit morphology similar to A ion channels.[86, 90] 
Investigations using ThT staining and further MD simulations have suggested that PG-1 
forms fibrils in water with twisted -sheet morphology showing a cross -structure which 
is also observed in amyloid fibrils.[86] These results and its restrained structure could po-
tentially make PG-1 a good candidate for a -hairpin model in the gas phase.  
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Due to the importance of the disulfide bonds in the stabilization of the -hairpin confor-
mation and in the biological activity of PG-1[87], we first performed IM-MS studies of the 
monomer both with open and closed disulfide bridges. The reduction of the disulfide 
bonds were carried out with 2-mercaptoethanol (ME) via the nucleophilic attack of the 
disulfide bond by ME and generation of a mixed disulfide intermediate.[91] The efficiency 
of the reduction with ME was confirmed by measuring the high-resolution mass spectra 
of the intact and reduced peptides. 
Figure 22 shows the ATDs and the experimental CCs of the monomeric species before 
and after reduction of the disulfide bonds. As expected, the monomers with open disul-
fide bridges show slightly longer drift times as the reduction of the number of intermolec-
ular interactions within the -hairpin can lead to more expanded conformers. The dia-
gram presented in Figure 23 shows the increase of the CCSs with charge state for the 
monomeric species. For both intact and open species in general, Coulomb repulsion 
leads to unfolding of more compact structures at low charge states into more extended 
conformations at higher charge states. Interestingly, no significant difference in the ex-
perimental CCSs for the doubly charged monomers was observed (395 Å2 and 393 Å2 for 
intact and open monomer, respectively). At lower charge states the disulfide bonds stabi-
lize the structure of the -hairpin and the electrostatic repulsion does not lead to a sub-
stantial change in CCSs. The effect of the disulfide bond breakage on the structure be-
comes more significant as the charge increases. All in all, the charge-induced unfolding 





Figure 22. ATDs of the monomeric PG-1 ions with intact and reduced disulfide bonds. 
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Figure 23. Plot of CCS vs. charge state for monomeric PG-1 with intact and reduced disulfide 
bonds. 
In order to perform action spectroscopy with the PG-1 monomers, we again make use of 
the complexation ability of amino acid side chains with crown ethers. Protegrin possess 
six arginine residues with high affinity to dibenzo-30-crown-10 molecules (db30c10). The 
protonated guanidinium side chain of arginine residues form stable noncovalent com-
plexes with db30c10 in the gas-phase. The stabilization of these complexes occurs 
through hydrogen bonding and ion dipole-interactions between the protonated guanidini-
um group and the 10 oxygen atoms of the crown-ether.[92] Prior to spectroscopy experi-




 to the m/z-value of the bare ions, where 536,26 u is the exact mass of 
db30c10, z is the charge of the monomer and n is the number of complexed crown 
ethers (n=0 to 6). However, not all the possible adducts were observed in a measurable 
quantity. 
The increase in the molecule’s CCSs as the number of db30c10 increases is an ex-
pected effect due to the mass and size addition of each crown ether to the complex. 
Nonetheless, a counter effect is observed for +2 ions. The addition of the first db30c10 
leads to a decrease of 7% in relation to the bare monomer’s CCS and the second crown-
ether increases the CCS only in 1.5% (See Appendix A.3 and Table A.1). This compac-
tion effect was previously observed for specific peptides and charge states by Warnke et 
al. and is a result of the capping charged lysine residues that have no proximate interac-
tion partner. In solution, the protonated guanidinium side chains of the arginine residues 
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are either involved in salt bridges with TFA counter-ions or in interaction with solvent 
molecules.[84] In the absence of solvent, the charged side chains take part in intramolecu-
lar interactions, coordinating to the backbone carbonyl groups, which will not be available 
to participate in stabilizing hydrogen bonds. The disruption of the hydrogen bonds within 
the protein backbone can lead to the destabilization of the secondary and tertiary struc-
tures. When db30c10 is added, the protonated arginine side chains are capped with the 
crown-ether molecules. For the +2 ions the complexation of the first two db30c10 adds to 
two of the arginine side groups leading to a stabilization of a more compact structure. 
An interesting observation is the increase in population of the compact conformer with 
cross section of 455 Å2 of the bare quadruply charged monomer (m/z 539) when 
db30c10 is present in the solution. A possible explanation is that the attachment of 
db30c10 stabilizes the compact conformer in solution, whose structure is transferred into 
the gas-phase and the detachment takes place in the entrance funnel prior ion mobility 
separation. Alternatively, variations in the instrument settings such as needle voltage 
could promote the population of this conformation between two measurements. 
To obtain more information on the secondary structure of the monomers, IRMPD spec-
troscopy was performed with the bare +3 ion, and with +3, +4 and +5 ions containing 3, 3 
and 5 db30c10 molecules, respectively. The +4 ion containing 4 crown ether molecules 
was not investigated due to its similar m/z-ratio with other complexes and the limited 
mass resolution of the quadrupole mass filter. The obtained spectra are shown in Figure 
24. All investigated monomeric species feature an amide I band centered around 1663–
1665 cm-1. This spectral region is typical for helical and type II -turn secondary struc-
tures. According to Farhner et al., the monomeric PG-1 in solution is described as an 
antiparallel -sheet arrangement from residues 4 to 8 and 13 to 17 containing mostly 
non-polar amino acid residues whereas the residues 9–12 form the loop region charac-
terized as a type II -turn where the positive arginine residues are clustered.[93, 94] How-
ever, the residues 1–3 and 18 are not involved in the hydrogen network that stabilizes 
the -sheet arrangement and were reported to be unstructured regions.[93, 94] The spec-
tral position around 1660 cm-1 is difficult to interpret because two different structural mo-
tives can absorb here. With respect to the restrained structure, the IR signature for the 
monomers of PG-1 possibly indicates the presence of a type II -turn secondary struc-
ture. 
A noticeable feature present in all spectra of the monomeric protein-db30c10 complexes 
shown in Figure 24 is the high intensity of the peak near 1500 cm-1. To ascertain the 
origin of this intense band, the ion of m/z 554 corresponding to the db30c10+NH4
+ adduct 
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is investigated and the spectrum is shown in Figure 24-e. The result shows that this peak 
mainly stems from vibration of the db30c10 and not from backbone amide I vibrations. 
The strong absorption at 1496 cm-1 close to the position of the amide II band is related to 




Figure 24. IRMPD spectra of m/z- and conformer-selected PG-1-crown ether adducts. The 
region colored in pink demarcates the typical absorption region for -helix secondary struc-
ture. The spectrum of the adduct with m/z=941 were recorded from 1550 to 1750 cm-1. 
As the -sheet content increases with oligomer size, we further performed oligomer-
selective IRMPD spectroscopy using higher concentrated solutions to investigate the 
PG-1 assembly into dimers and trimers. Figure 25 shows the IRMPD spectra of the di-
meric and trimeric PG-1. The spectra were acquired at low laser power settings so that 
the amide II band shows low intensity and the amide I band is well-resolved. The spectra 
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of both species feature broad and asymmetric amide I bands so that only the position 
determined by the FMHW is not a good indicative of the secondary structure content of 
the molecule. The maximum absorption for the dimer and trimer occurs at 1650 cm-1 and 
1645 cm-1 respectively. In addition to this main absorption regions, the dimer amide I 
band displays high intensities around 1670–1685 cm-1 and a shoulder at lower wave-
numbers (approximately at 1625–1630 cm-1). The same characteristic shoulders with 
lower intensity can also be observed at both sides of the amide I band in the spectrum of 
the +3/4 ion. These secondary spectral bands indicate a population of C=O oscillators 
absorbing at these wavenumbers, and therefore suggest the presence of more than one 
structural family. Although the absorption between 1645 and1650 cm-1 is the typical re-
gions observed for random coil and -helix secondary structures, the spectral bands at 
lower and higher wavenumber also suggest antiparallel -sheet structures. One would 
expect, in this case, the maximum absorption around 1630 cm-1, as a characteristic ab-
sorption for -sheets. However, a -hairpin absorbs at higher wavenumbers, because the 
vibrational excitons can delocalize over only two strands rather than 3 or more, which is 
necessary for lower -sheet vibrational frequencies.[47] Another possible reason for the 
higher vibrational frequencies are the free C=O oscillators in the positions 1–3 which are 
possibly not involved in a strong hydrogen bonding network in the monomer.  
The implication of antiparallel -sheet arrangement is in agreement with previous MD 
simulations performed by Jang et al. which proposed two models for the dimer assembly: 
an antiparallel -sheet with a turn-next-to-tail (shown in Figure 27) and a parallel -sheet 
with a turn-next-to-turn.[94] In the turn-next-to-tail association, the characteristics of the 
amide I band of the gas-phase IR spectrum of the dimers and trimers supports the as-
sumption of an antiparallel arrangement between the monomers. To estimate the -sheet 
content, we deconvoluted the amide I region for the +2/3 ion (Figure 26). The deconvolu-
tion reveals a -sheet content of 38% by employing the expected characteristic absorp-
tions of the -sheet secondary structures as constraints. Although this value is in agree-
ment with previous results and modeling, this is only an approximation since is not pos-




Figure 25. IRMPD spectra of m/z- and conformer selected PG-1 oligomers. The regions col-
ored in blue and pink demarcate the typical absorption regions for -sheet and -helix sec-
ondary structures, respectively.  
 
Figure 26. Deconvolution of the amide I band of the PG-1 dimer. 
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Figure 27. Topological diagram of PG-1 A) monomer and B) dimer in antiparallel -sheet. 
Solid lines indicate the disulfide bonds, and dotted lines indicate hydrogen bond. Positively 
charged Arg residues are depicted by purple beads, whereas polar and hydrophobic resi-
dues are depicted by shell pink and white beads, respectively. Reproduced from Jang et al.[94] 
In conclusion, despite the well-established structure of PG-1 monomers in solution, the 
gas-phase spectra cannot be used as a model for a -hairpin. In contrast to the -helix 
secondary structure, which is defined by a uniform and well-defined conformation, -
sheet and -hairpin comprise a much broader conformational class involving a wide 
range of topologies as a result of different assemblies of multistranded arrays[95], and 
therefore, the seek for an ideal model for monomeric -hairpin in the gas-phase is chal-
lenging. However, characteristic signatures for -hairpin start appearing for oligomers. 
Based on the broad and asymmetric features of the amide I band, i.e. a secondary popu-
lation of oscillators absorbing at higher and lower vibrational frequencies, the spectrum 
of the PG-1 low-order oligomers could in principle be used as a reference for -sheet 
content. 
4.2 Human Islet Amyloid Polypeptide 
 
Aggregation of human islet amyloid polyeptide (hIAPP) and extracellular accumulation of 
amyloid plaques has been increasingly associated with the pathogeny of type 2 diabe-
tes.[10] Recent studies have proposed that early intermediary oligomers are the toxic spe-
cies instead of the mature fibrils and different aggregation trajectories and oligomeriza-
tion pathways for hIAPP have emerged supported by different experimental techniques 
in combination with theory.  Interestingly, although they differ only in six amino acid resi-
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dues in the “core mutation region” (R18H, L23F, P25A, V26I, P28S, and P29S, as shown 
in Figure 28), human IAPP forms fibrils composed by highly ordered -sheet structures 
while rat IAPP does not form fibrils.[96]  
 
Figure 28. Comparison of primary structure of hIAPP and rIAPP. The section colored in grey 
show the amyloidogenic region (22–28). The cyan section represents the segments with 
high affinity toward metal ions. Differences in residues in the primary sequence of rIAPP are 
emphasized in red. Figure taken from Alghrably et al.[11] 
Using a combination of IR spectroscopy and IM-MS, we here investigate the structure of 
the isolated early aggregation species, i.e. monomers and dimers, as well as differences 
between human and rat IAPP. The mass spectrum of hIAPP shows mainly the triply and 
quadruply charged monomers as well as the quintuply charged dimer. Smaller peaks can 
be assigned to the 1/5 and 2/7 ions. Higher-order oligomers are observed for neither the 
aforementioned peptide solutions nor solutions with higher peptide concentrations. The 
protonation sites on rIAPP are likely the Lys1, Arg11, and Arg18 residues for the 3+ 
charge state and protonation of the N-terminus generates the +4 ion. The +3 charge 
state of hIAPP arises from protonation of the Lys1 and Arg11 residues and the N-
terminus. Further protonation of His18 gives rise to the +4 charge state. The protonation 




Figure 29. nESI time-of-flight mass spectra of hIAPP solution. 
 
The first conformational insight into the monomers and dimers are obtained from ion-
mobility experiments. Figure 30 shows the ATDs for the monomeric and dimeric ions of 




Figure 30. ATDs of hIAPP and rIAPP ions. 
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Table 4. Measured CCSs of m/z-selected hIAPP and rIAPP ions. 
Peptide CCS (Å2) 
hIAPP 
1/4 647 753  
1/3 572 630  
2/5 1141   
2/7 1327 1358   
rIAPP 
1/4 588 618  
1/3 612 639  
2/5 1014 1070  
2/7 1299 1340 1400 
 
The ATDs of both hIAPP and rIAPP indicate the presence of two dominant groups of 
conformers for the +3 and +4 charge states as well as for the dimers. The +3 hIAPP 
have two major conformers with CCSs of 572 and 630 Å2, and +3 rIAPP two conformers 
with 612 and 639 Å2. The ATD of the +4 hIAPP shows two baseline separated peaks 
with CCS of 647 and 753 Å2 while the ATD of the +4 rIAPP features two less well-
resolved peaks with CCSs of 588 and 618 Å2. The ATD for the quintuply protonated di-
mer of hIAPP has one major feature at longer drift times with a CCSs of 1141 Å2 and the 
dimeric rIAPP shows two main peaks with CCS of 1014 and 1070 Å2. In addition, 2/7 
hIAPP and rIAPP ions were observed from the solutions containing Zn(II) and Cu(II), 
respectively. The broad shape of the ATDs, however, suggests the presence of minor 
structural families contributing to the arrival time distributions.  The extended +3 con-
former has a CCS that is 10% larger than compact conformer while the extended +4 con-
former is 16% larger in CCS than its compact conformer. This large difference in CCS for 
the +4 ion suggests two conformational families with significantly different secondary 
structures.  
Yet, the performed ion mobility studies do not provide direct experimental information 
about the secondary structure and structure assignment solely based on computational 
simulations can lead to erroneous interpretation. Here, we performed IRMPD spectros-
copy of the early monomeric intermediates to extract further structural information. The 





Figure 31. IRMPD spectrum of m/z- and conformer-selected hIAPP monomers. The region 
colored in pink demarcates the typical absorption region for -helix secondary structure. 
 
The IR spectra of the compact and extended +4 ions feature narrow amide I bands cen-
tered around 1665 cm-1. They also display a characteristic maximum absorption at 1661 
cm-1 and the most compact conformer a second maximum absorption at 1673 cm-1. The 
spectrum of the +3 ion displays a broader amide I band centered at 1671 cm-1 with max-
imum absorptions at 1661 and 1679 cm-1. It is important to emphasize the reproducibility 
of the maximum absorptions and the shape of the amide I band displayed by the mono-
mers. Further, based on the knowledge that amyloidogenic oligomers are mainly com-
posed of -sheet structures and on previous observations that the extent of -sheet in-
creases with the oligomer size[49], we also investigated the secondary structure of the 
dimer (Figure 32). The dominant conformer of +2 /5 shows amide I band centered at 
1663 cm-1 and maximum absorption at 1656 cm-1. The spectrum of the extended con-
former of the 2/7 ion displays a symmetric amide I band centered at 1663 cm-1, whereas 
the compact conformer has a amide I band positioned at 1665 cm-1. 
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Figure 32. IRMPD spectrum of m/z- and conformer-selected hIAPP dimers. The region col-
ored in pink demarcates the typical absorption region for -helix secondary structure. 
 
The similar characteristics compared with the IRMPD spectrum of polyalanine (Figure 
17) presumably suggest a considerable extent of -helix motifs within the peptide. The 
absence of -sheet signature in the IR spectra of the monomers and dimers is consistent 
with results stemmed from solution-phase techniques previously reported by other 
groups.[41, 49] 
In order to investigate structural characteristics of rIAPP oligomers that are related to its 
lack of amyloidogenicity, we also performed IR spectroscopy of the rIAPP species. The 
IRMPD spectra of the rIAPP monomers shown are shown in Figure 33. The amide I 
bands for both the compact and extended quadruply protonated monomers are centered 
at 1668 cm-1. The compact conformer amide I band is slightly asymmetric showing a 
maximum absorption at 1660 cm-1. The IRMPD spectra of +3 ions feature symmetric 
amide I bands centered around 1670 cm-1. The spectrum of the compact conformer of 
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the 2/5 rIAPP ion (Figure 34) displays an amide I band positioned at 1661 cm-1, while the 
amide I band of the extended dimer is centered 1657 cm-1. 
The spectral features displayed by all the investigated species indicate predominance of 
helical structures. The higher vibrational frequencies shown by the +3 ions suggest the 
presence of turn-like motifs. Identification of spectral features that can be assign to -
helix motifs is in good agreement with previous solution NMR studies, which shows that 
the residues 5–19 adopt -helical conformations[47], and with REMD simulations which 
also predicted -helix- and turn-based structural families for the +4 rIAPP monomers.[8] 
The absence of -sheet structure for the rIAPP monomers is already expected as the rat 
form is known to be stable and non-amyloidogenic. The difference in the structure be-
tween the human and rat IAPP lies on the mutations sites in the region high -sheet pro-
pensity. This region in the rIAPP sequence contains proline mutations which has an in-
trinsic low amyloidogenicity and are disruptive to secondary structure. Moreover, proline 
isomerization leads to multiple stable conformations of the peptide backbone, as can be 




Figure 33. IRMPD spectrum of m/z- and conformer selected of rIAPP monomers. The region 
colored in pink demarcates the typical absorption region for -helix secondary structure. 
The absence of -sheet features in the amide I band for monomeric and dimeric hIAPP 
species contrasts the aggregation mechanism where toxic -sheet-rich oligomers are 
formed before nucleation. On the other hand, the results presented here suggest that 
another mechanism take place in the aggregation of hIAPP. Unfortunately, in the exper-
imental conditions employed any higher-order oligomers were observed in a measurable 
quantity. 
The aggregation process of amyloid peptides can be followed by FTIR spectroscopy. 
The solution-phase IR spectra of hIAPP and rIAPP shown in Figure 35 were recorded 
during 24 hours. The IR spectrum of hIAPP clearly shows the transition of random coil 
(1648 cm-1) and -helix structures to b-sheet-rich aggregates (1617 cm-1). The formation 
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of -sheet-rich fibrils could be observed after 40 minutes. We also measured the solu-
tion-phase IR spectrum of rIAPP. The broad amide I band reveals an average of -helix 
(1656 cm-1), random coils (1641–1648 cm-1) and -sheet (1626 cm-1) structures in solu-
tion. In contrast to hIAPP, no shift can be observed in the amide I band of rIAPP over 
24h due to its stability towards fibril formation.  
 
Figure 34. IRMPD spectrum of m/z- and conformer selected of rIAPP dimers. The region 











4.3 hIAPP – metal adducts 
 
In addition to amyloid formation, elevated serum copper levels and zinc deficiency are 
also observed in patients affected by T2D. Several studies also have found correlation 
between the loss of fibril formation and metal-hIAPP association, suggesting that metal-
coordination plays a role in hIAPP aggregation. We investigate here possible conforma-
tional changes upon adducts formation between hIAPP with Zn2+ and Cu2+ ions.  
The measured mass spectra depicted in Figure 36 presents the similar charge distribu-
tion as the one obtained from the pure hIAPP solution. In addition to the +3 and +4 met-
al-free hIAPP monomers, the metal-associated +4 and +5 hIAPP are also observed with 
relatively high intensity. The relative intensity between the holo ([hIAPP+M2++2H+]4+, 
where M2+ is the metal ion) and apo ([hIAPP+4H+]4+) form is bigger for the Cu(II)-hIAPP 
than for the Zn(II)-hIAPP adduct. The relative affinity of copper towards toward hIAPP (Ka 
~8.9 x 107 M-1) is larger than for zinc (9.1 x 105 M-1).[67] The higher affinity of Cu(II) toward 
hIAPP can also be used to explain the wider variety of adducts formed, including Cu(II) 
complexed with dimeric. 
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Figure 36. nESI time-of-flight mass spectra of A) Zn(II)- and B) Cu(II)-containing hIAPP solu-
tions. 
 
To better understand the role of metals in hIAPP structures, we investigated the confor-
mational features of metal-associated hIAPP monomers and compared these to metal-
free hIAPP. The measured ATDs for Zn(II)- and Cu(II)-bound hIAPP ions are shown in 
Figure 37 and 38. In addition to the major compact and extended conformers observed 
for the metal-free 4+ state, a third structural family with a CCS of 687 Å2 is present for 
the Zn(II)-associated 4+ ion. The +5 charge state was also observed as a single con-
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former with cross section of 772 Å2. The ATD for the +6 monomer features two equals 
populated structures with cross sections of 793 and 847 Å2.  
 It is interesting to compare the ATD features of +4 metal-free hIAPP and Zn(II)-hIAPP. 
The relative abundance of the compact and extended conformers also change upon 
metal association. In the absence of metal ions, +4 hIAPP exists mainly in a compact 
conformation. When Zn(II) is added to the solution, the relative population of the extend-
ed structural family increases. This result suggests a higher affinity of Zn2+ by the ex-
tended conformer. In addition, our results show three well resolved peaks corresponding 
to three structural families for the +4 monomers.  
We detected a similar trend for the Cu(II)-associated hIAPP. Cu(II) also preferentially 
binds to the extended hIAPP +4 monomer, and a third conformation with CCS of 702 Å2 
emerges from Cu(II)-hIAPP interaction. The broad ATDs for +3 and +4 ions bound to one 
and two copper atoms, respectively, indicate various conformations. For these species, 
multiple Gaussians were fitted and main features with cross sections of 621, 688 and 
754 Å2 for the +4 ion and 593 and 626 Å2 for the +3 ion were assigned as the dominant 
structures. The results presented here contrast with the results reported by Lee and 
coworkers, which predict that Cu(II) preferentially associates to the compact hIAPP 
monomer. 
At a first glance, the information obtained from the ion mobility studies suggests that both 
Zn(II) and Cu(II) in solution increase the relative abundance of the extended conformer. 
According to the Bowers’s group, the extended conformer corresponds to a -hairpin 




Figure 37. ATDs of m/z-selected Zn(II)-hIAPP adducts. 
 
Figure 38. ATDs of m/z-selected Cu(II)-hIAPP adducts. 
 
The secondary structure of hIAPP-metal adducts were probed by irradiation with IR light. 
The IRMPD spectra of the Zn(II)-hIAPP in the +4 charge state are shown in Figure 39. 
The center of the absorption band determined at the FWHM matches the amide I fre-
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quency in polyalanine (see Figure17). Yet, the peak of the most compact conformer ap-
pears to have two maximum at 1660 and 1677 cm-1 with equal intensities. The second 
compact conformer shows only one maximum at 1660 cm-1 and the second maximum 
reappears with weaker intensity in the amide I band of the most extended conformer. 
Likewise, the three Cu(II)-hIAPP conformers show absorption bands centered at 1667 
cm-1 (see Figure 40). The amide I band of the most compact conformer also shows two 
maximum at 1660 and 1673 cm-1. The center of the absorption band of the conformer 
with a CCS of 702 Å2 matches with its maximum. In addition to maximums at 1658 and 
1676 cm-1 can also be observed. The highest intensity of the absorption band of the most 
extended conformer occurs at 1660 cm-1. 
All the investigated species show spectral features typical of -helical structures. This 
suggests that segments within the molecules possibly adopt -helical conformations. 
The high population of C=O bonds in the compact Zn-hIAPP monomer absorbing at 
1677 cm-1 might indicate also the presence of turn-like structures inside the peptide. 
These structures are also present in smaller proportions in the most extended monomer. 
Moreover, a slight blue shifted in the frequency in relation to the second maximum ob-
served for the metal-free hIAPP +4 monomers, could suggest a local rearrangement 
within a turn-like motif to accommodate the zinc ion. The similar spectral features ob-
served for the Cu-associated hIAPP species demonstrate that zinc- and copper-bound 
hIAPP adopt related secondary structures.  
The similar content of secondary structures within the Zn- and Cu- associated hIAPP 
monomers even though Cu(II) and Zn(II) are reported to induce distinct hIAPP aggrega-
tion pathways, is an interesting result. According to the spectroscopic data, metal ions do 
not preferentially bind to a -hairpin, but rather to an extended -helix-rich conformation. 
Different effects and aggregation pathways have been proposed by other groups based 
on theoretical simulations, TEM, IM-MS and solution-phase spectroscopy. Our results, 
however, do not show any change in the morphologies of the early monomers and oli-
gomers formed prior aggregation. It is also difficult to predict if metal ions have a toxicity 
inducing or inhibitory effect since it is still unclear which conformers are the toxic species 




Figure 39. IRMPD spectra of Zn(II)-associated [hIAPP+Zn+2H]4+ monomeric ions. The region 





Figure 40. IRMPD spectra of Cu(II)-associated [hIAPP+Cu+2H]4+ monomeric ions. The region 





Observation of coaggregated heterogeneous pepetides in vitro and also the presence of 
hetero-associated pepetided in vivo have been giving evidence for a prion-like interplay 
occurring between various amyloidogenic proteins. The association between prion 
(PrP106–126) and IAPP is particularly interesting as they show almost no sequence homol-
ogy, and yet heterogeneous fibrils and aggregates have been observed.[97] In this thesis 
we performed IM-MS and IRMPD experiments in order to elucidate structural changes as 
a consequence of the heterogeneous co-assembly. 
Heterodimers hIAPP:PrP and rIAPP:PrP were observed at the +4 and +5 charge states. 
The ATDs of hIAPP:PrP dimer at +4 and +5 charge states (Figure 41) show one domi-
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nant conformer for each species with cross section of 984 and 981 Å2 respectively. In 
addition to the compact and extended conformations, a third structural family of the +4 
heterodimer is populated with a cross section of 721 Å2. The ATDs of the rIAPP mono-
mers and heterodimers are likewise interesting. The most compact structure with cross 
section of 588 Å2 is not observed in the presence of PrP in the solution, but two extended 
conformers emerge in these conditions with cross sections of 721 and 749 Å2, similarly 
as observed for hIAPP. These results suggest that PrP induces the formation of extend-
ed conformations in both peptides, even though they show distinct propensities to ag-
gregate. At the +4 charge state, the ATD of rIAPP:PrP heterodimers shows two dominant 
peaks with CCS of 934 and 1669 Å2, the latter being assigned to the (4+4)/8 hetero-
oligomer. The +5 heterodimers show a compact structure of 933 Å2 and an extended 
structure with 1050 Å2. The compact structures at both charge states have similar cross 
sections to hIAPP:PrP heterodimers, suggesting similar interaction between these two 
peptides and prion. 
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Figure 41. ATDs of m/z-selected hIAPP and rIAPP monomers and hIAPP:PrP106–126 and 
rIAPP:PrP106–126 heterodimers. 
To gain insight on the content of secondary structures of the early oligomers, the hIAPP 
and rIAPP monomers as well as their heterodimers were further investigated with IR la-
ser light. The IRMPD spectra (Figure 42) of the (1+1)/4 and (1+1)/5 hIAPP heterodimers 
resemble each other, where both feature amide I bands centered at 1664 cm-1. The 
IRMPD spectra of the intermediary and extended +4 monomers (Figure 43) show asym-
metric amide I bands centered around 1664 cm-1 with high intensities at lower (~ 1642 
cm-1) and at high wavenumbers (~1685 cm-1). The IR spectrum of the hIAPP +3 mono-
mer also shows a blue shifted amide I band. Its central position is located at 1671 cm-1 
with high intensities around 1690 cm-1. 
The IRMPD spectra of the rIAPP 4+ monomers and rIAPP:PrP106–126 heterodimers are 
shown in Figure 44. The spectrum of the heterodimer at +4 charge state features an am-
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ide I band centered at 1667 cm-1, while the +5 heterodimer shows amide I bands posi-
tioned at 1661 cm-1. Figure 45 shows the IRMPR spectra of the rIAPP monomers meas-
ured from the solution containing PrP106–126. The conformer with a cross section of 611 Å
2 
has an amide I band centered at 1671 cm-1. A slight red shift is observed for the mono-
mer with CCS of 720 Å2 whereas the spectrum of the most extended conformer with 
CCS of 753 Å2 shows an amide I band shifted to higher wavenumbers. 
The absorption frequencies and the shape of the bands displayed be the investigated 
species suggest structurally distinct conformations. The center of the amide I band fea-
tured by both dimers matches with the position of its maximum intensity in the typical 
region of -helix structures. As reported by Ilitchev et al., the region 8-20 of hIAPP is 
responsible for interaction with PrP. This region is known to adopt  helical confor-
mation.[97] Interestingly, the spectra of the hIAPP monomers originating from the solution 
containing PrP106–126 resemble the spectra of the PG-1 oligomers rather than spectra of 
hIAPP from the pure solution. Since the amide I bands of PG-1 dimer and trimer spectra 
are also flanked on both sides, comparing these spectral features could suggest in prin-
ciple some antiparallel -sheet content within the hIAPP monomer. However, the spectra 
of the monomers in the solution containing PrP106–126 were acquired at higher power set-
tings than those measured from the pure hIAPP solution. Therefore, the saturation of the 
band can lead to an erroneous assignment of -hairpin motif. 
Similar to hIAPP:PrP106–126 heterodimers, the spectroscopy results suggest that rIAPP 
and PrP106–126 also associate into -helix-rich structure. Moreover, the spectral features 
displayed by the rIAPP monomers indicate different hydrogen networks in the individual 
species. The lower vibrational frequency possibly indicates a higher extent of hydrogen 
bonding within a helical-rich structure. 
The differences in the spectra of the hIAPP and rIAPP monomers measured from the 
pure and PrP106–126-containing solution imply that an equilibrium exists between the het-
erodimers and monomers in solution. After association, the PrP106–126 seems to induce 
the formation of new structures as well as structural changes in hIAPP and rIAPP mon-
omers as indicated by shifts in the absorption frequencies. 
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Figure 42. IRMPD spectra of m/z- and conformer-selected hIAPP-PrP106–126 heterodimers. 





Figure 43. IRMPD spectra of m/z- and conformer-selected hIAPP monomers measured from 
the PrP106–126-containing solution. The regions colored in blue and pink demarcate the typi-
cal absorption regions for -sheet and -helix secondary structures, respectively.  
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.  
Figure 44. IRMPD spectra of m/z- and conformer-selected rIAPP-PrP106–126 heterodimers. 





Figure 45. IRMPD spectra of m/z- and conformer-selected rIAPP monomers measured from 
the PrP106–126-containing solution. The region colored in pink demarcates the typical absorp-
tion region for -helix secondary structure. 
Here we show the advantage of performing IR spectroscopy of m/z- and conformer-
selected oligomers. Although both peptides show additional structural families of similar 
cross sections in the presence of PrP, we prove differences between the secondary 
structures adopted by the distinct conformers. While the most extended hIAPP monomer 
absorbs at 1664 cm-1, indicating mainly -helix structures, the most extended rIAPP con-





Insulin is a hormone cosecreted and coregulated at the expression level with hIAPP. 
Both peptides share the same secretory pathway in the pancreatic -cells and have have 
complementary hormone activities. The inhibitory effect of insulin on hIAPP aggregation 
in vitro has previously been reported and the hIAPP/insulin co-assembly is believed to 
play an important role in type II diabetes. AFM studies on hIAPP/insulin co-assembly 
revealed distinctly different fibrillary structures formed by hIAPP in the absence and 
presence of insulin and these are insulin concentration-dependent.[98] Yet little is known 
about the mechanism of inhibition and which hIAPP intermediate oligomers are target by 
insulin peptides. Insulin is composed of an A-chain (IAC) and a longer B-chain (IBC) 
which includes the high amyloidogenic 12–17 VEALYL sequence. Here we investigate 
the hIAPP:VEALYL co-assembly using IM-MS and gas-phase IR spectroscopy. 
In addition to the singly protonated VEALYL and the hIAPP monomers, the measured 
mass spectrum shows also the [hIAPP+VEALYL]+3, [hIAPP+VEALYL]+4 and 
[2hIAPP+VEALYL]+5 heterodimers. The measured ATDs of the m/z- selected species are 
shown in Figure 46. The +3 ion ATD was fitted with a single structure with cross section 
of 673 Å2 and two main structural families with cross sections of 698 and 734 Å2 provided 
the best fit for the +4 ATD. 
 
Figure 46. ATDs of m/z- selected hIAPP:VEALYL heterodimers. 
 
To obtain structural details on the formed heterodimer, we measured the IR spectrum of 
m/z- and drift-time-selected heterodimer at the +3 charge state (Figure 47). The other 
two heterodimers observed in the mass spectrum were not detected in a measurable 
quantity to perform IRMPD spectroscopy. The spectrum shows a narrow and symmetric 
amide I band centered at 1666 cm-1. This vibrational frequency matches with the position 
of the band of the model peptide polyalanine. 
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The spectroscopy data suggests that the helical fraction within the peptide is preserved 
during its association with VEALYL. Hetero-oligomerization occurs upon formation of 
intrapeptide hydrogen bondings at the interface between the peptides, and consequently 
the additional perturbation on the C=O bonds shifts the vibrational frequency to lower 
wavenumbers. Estimation of helical conformations within the molecule is in agreement 
with reported simulations on the heterodimer and with the inhibitory mechanism of ag-
gregation by insulin previously proposed.[99] By forming the helix/helix hIAPP:insulin 
complex, the oligomerization pathway is shifted away from the formation of -sheet rich 
oligomers and occasionally the -barrel toxic structures., thus preventing aggregation. 
 





5. CONCLUSION AND OUTLOOK 
 
Type 2 diabetes mellitus is a systemic disorder that affects millions of people around the 
world. Along with insulin resistance, pathophysiological aggregation of hIAPP is a hall-
mark of this disease. The amyloid hypothesis associates the amyloid formation with loss 
of pancreatic -cell mass. However, the underlying mechanism of aggregation is barely 
understood to date. The aim of this thesis was to investigate the gas-phase secondary 
structure of early hIAPP oligomers using ion mobility spectrometry in combination with IR 
spectroscopy in the gas phase.  
Selected hIAPP monomers and dimers from the soluble ensemble were investigated in 
the gas phase. In previous ion mobility spectrometry studies, a -hairpin conformation 
has been assigned to the extended +4 monomeric ion. In contrast, the non-
amyloidogenic rIAPP ions were reported to consist mainly of random coil and turn-like 
structures. The typical IR spectral signature for -sheet secondary structures is an ab-
sorption band around 1630 cm-1 (for parallel -sheet) and a second band around 1690 
cm-1 (for antiparallel -sheet). Yet, a -hairpin IR signature could, not be unambiguously 
assigned to the IR spectra of the investigated hIAPP species. Nevertheless, the extend-
ed +4 monomer and also the investigated dimer show a systematic shift to lower wave-
numbers in relation to the +3 monomer indicating a difference in the structure of these 
ions. 
Recent research has speculated the role of transition metals and other peptides in induc-
ing structural transitions in hIAPP and in interfering in its aggregation pathway. There-
fore, m/z- and conformer-selected of metal-associated hIAPP and heterodimeric ions 
were interrogated with IR radiation. By comparing the IR spectrum of metal-free hIAPP 
and metal-hIAPP adducts, coordination with Zn and Cu ions do not seem to induce any 
significant changes in the secondary structure within the monomers. Moreover, although 
different interaction modes and mechanisms of aggregation induced by metal-binding 
have been proposed for both Zn and Cu, Zn- and Cu-hIAPP show a comparable IR sig-
nature suggesting similarities in their secondary structure. 
Possible changes in the secondary structures resulting from interaction with a fragment 
of the prion protein and with the hexapeptide VEALYL of the protein insulin were investi-
gated. Both PrP106–126 and insulin have been reported to have an impact on hIAPP ag-
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gregation. In the investigated species, the heterogeneous co-assembly does not induce 
significant changes in the secondary structure of hIAPP. The IR spectra of the heterodi-
mers are comparable to the IR spectra of pure hIAPP. Yet, an interesting observation 
can be made: additional features appear in the IR spectra of the hIAPP monomers ion-
ized from solutions containing PrP106–126. Absorptions at lower and higher vibrational fre-
quencies possibly suggest the transition to a -sheet-like structure in these species. 
ATR-FTIR is an established analytical method to follow the aggregation pathway and 
secondary structure transition of amyloidogenic peptides in condensed phase. The solu-
tion-phase IR spectrum of hIAPP was acquired over 24. The experimental data show 
that the soluble intermediate oligomers were mainly composed of random-coils and -
helical structures, whereas the insoluble fibrils are mainly composed of -sheet motifs. In 
contrast but in agreement with previous publications, the ATR-FTIR spectrum of rIAPP 
did not suggest any change in secondary structure. 
To date, two mechanisms for hIAPP aggregation have been proposed. The first suggests 
that a large-scale conformational transition from disordered oligomers to highly ordered 
-sheet-rich oligomers occurs during the last stages of the aggregation pathway.[100] The 
second possible mechanism, referred as the “early conformation transition” proposes 
that a transition to -sheet structures occurs before nucleation. The results obtained in 
this work reveal significant contributions of -helical structural families within the hIAPP 
monomers and dimers. Recent theoretical work predicts that transition to -sheet be-
comes significant starting from hexamers. In order to identify which of the two proposed 
mechanism takes place, more information on the secondary structure of higher-order 
oligomers is necessary. 
Signatures of -sheets and -hairpins, as these are known from classical solution-phase 
approaches, were also not observed for the model molecules investigated in this thesis. 
These have well-defined and intensively studied secondary structures in solution. The 
results suggest that the absence of a β-sheet signature in the IRMPD spectra does not 
necessarily correlate with the lack of β-sheet motifs in solution. Even though nESI is a 
soft-ionization method, the native-like structures of these molecules are possibly lost and 
β-sheet conformations are destabilized during transfer into the gas-phase. In this case, 
optimization of the experimental conditions that preserve the secondary structure of the 
peptides could increase the population of the native-like conformations, making their in-
terrogation with laser light possible. 
 75 
Conformational changes within the molecule could also arise from the IRMPD process. 
The increase in internal energy due to the sequential absorption of photons might lead 
not only to bond breakage but to the loss of the β-sheet-like motifs. Consequently, the 
segments of the molecule that undergo conformational transitions will no longer absorb 
IR light during the process. This can be overcome by using methods that use other types 
of action such as cold-ion IR spectroscopy in helium nano-droplets. In conclusion, further 
research is necessary to solve the “chicken-and-egg” problem, whether hIAPP aggrega-




[1] D. EISENBERG, M. JUCKER, CELL 2012, 148, 1188-1203. 
[2] S. M. BUTTERFIELD, H. A. LASHUEL, ANGEWANDTE CHEMIE IN-
TERNATIONAL EDITION 2010, 49, 5628-5654. 
[3] C. SOTO, NATURE REVIEWS NEUROSCIENCE 2003, 4, 49-60. 
[4] A. ABEDINI, A. PLESNER, P. CAO, Z. RIDGWAY, J. ZHANG, L.-H. 
TU, C. T. MIDDLETON, B. CHAO, D. J. SARTORI, F. MENG, H. WANG, A. 
G. WONG, M. T. ZANNI, C. B. VERCHERE, D. P. RALEIGH, A. M. 
SCHMIDT, ELIFE 2016, 5, E12977. 
[5] W. HOFFMANN, G. VON HELDEN, K. PAGEL, CURRENT OPINION 
IN STRUCTURAL BIOLOGY 2017, 46, 7-15. 
[6] S. D. MORAN, M. T. ZANNI, THE JOURNAL OF PHYSICAL CHEM-
ISTRY LETTERS 2014, 5, 1984-1993. 
[7] J. SEO, W. HOFFMANN, S. WARNKE, X. HUANG, S. GEWINNER, 
W. SCHÖLLKOPF, M. T. BOWERS, G. VON HELDEN, K. PAGEL, NATURE 
CHEMISTRY 2016, 9, 39. 
[8] N. F. DUPUIS, C. WU, J.-E. SHEA, M. T. BOWERS, JOURNAL OF 
THE AMERICAN CHEMICAL SOCIETY 2009, 131, 18283-18292. 
[9] C. UETRECHT, R. J. ROSE, E. VAN DUIJN, K. LORENZEN, A. J. 
R. HECK, CHEMICAL SOCIETY REVIEWS 2010, 39, 1633-1655. 
[10] L. HAATAJA, T. GURLO, C. J. HUANG, P. C. BUTLER, ENDO-
CRINE REVIEWS 2008, 29, 303-316. 
[11] M. ALGHRABLY, I. CZABAN, Ł. JAREMKO, M. JAREMKO, JOUR-
NAL OF INORGANIC BIOCHEMISTRY 2019, 191, 69-76. 
[12] J. D. SIPE, A. S. COHEN, JOURNAL OF STRUCTURAL BIOLOGY 
2000, 130, 88-98. 
[13] M. FÄNDRICH, V. FORGE, K. BUDER, M. KITTLER, C. M. DOB-
SON, S. DIEKMANN, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCI-
ENCES 2003, 100, 15463. 
[14] R. NELSON, M. R. SAWAYA, M. BALBIRNIE, A. Ø. MADSEN, C. 
RIEKEL, R. GROTHE, D. EISENBERG, NATURE 2005, 435, 773-778. 
[15] L. A. WOODS, S. E. RADFORD, A. E. ASHCROFT, BIOCHIMICA 
ET BIOPHYSICA ACTA (BBA) - PROTEINS AND PROTEOMICS 2013, 1834, 
1257-1268. 
[16] M. C. OWEN, D. GNUTT, M. GAO, S. K. T. S. WÄRMLÄNDER, J. 
JARVET, A. GRÄSLUND, R. WINTER, S. EBBINGHAUS, B. STRODEL, 
CHEMICAL SOCIETY REVIEWS 2019. 
[17] J.-X. LU, W. QIANG, W.-M. YAU, CHARLES D. SCHWIETERS, 
STEPHEN C. MEREDITH, R. TYCKO, CELL 2013, 154, 1257-1268. 
[18] T. SANKE, G. I. BELL, C. SAMPLE, A. H. RUBENSTEIN, D. F. 
STEINER, JOURNAL OF BIOLOGICAL CHEMISTRY 1988, 263, 17243-
17246. 
[19] P. CAO, P. MAREK, H. NOOR, V. PATSALO, L.-H. TU, H. WANG, 
A. ABEDINI, D. P. RALEIGH, FEBS LETTERS 2013, 587, 1106-1118. 
[20] P. WESTERMARK, A. ANDERSSON, G. T. WESTERMARK, PHYSI-
OLOGICAL REVIEWS 2011, 91, 795-826. 
[21] T. A. LUTZ, CELLULAR AND MOLECULAR LIFE SCIENCES 2012, 
69, 1947-1965. 
[22] A. YOUNG, IN ADVANCES IN PHARMACOLOGY, VOL. 52, ACA-
DEMIC PRESS, 2005, PP. 151-171. 
[23] M. STRIDSBERG, C. BERNE, S. SANDLER, E. WILANDER, K. 
ÖBERG, DIABETOLOGIA 1993, 36, 843-849. 
 VII 
[24] M. PETTERSSON, B. AHRÉN, ACTA PHYSIOLOGICA SCANDINA-
VICA 1990, 138, 389-394. 
[25] J. D. KNIGHT, J. A. WILLIAMSON, A. D. MIRANKER, PROTEIN SCI 
2008, 17, 1850-1856. 
[26] P. WESTERMARK, Z.-C. LI, G. T. WESTERMARK, A. LECK-
STRÖM, D. F. STEINER, FEBS LETTERS 1996, 379, 203-206. 
[27] G. T. WESTERMARK, D. F. STEINER, S. GEBRE-MEDHIN, U. 
ENGSTRÖM, P. WESTERMARK, UPSALA JOURNAL OF MEDICAL SCIENCES 
2000, 105, 97-106. 
[28] J. D. KNIGHT, A. D. MIRANKER, JOURNAL OF MOLECULAR BI-
OLOGY 2004, 341, 1175-1187. 
[29] X. ZHANG, J. R. ST. CLAIR, E. LONDON, D. P. RALEIGH, BIO-
CHEMISTRY 2017, 56, 376-390. 
[30] M. F. M. SCIACCA, J. R. BRENDER, D.-K. LEE, A. RAMAMOOR-
THY, BIOCHEMISTRY 2012, 51, 7676-7684. 
[31] J. A. WILLIAMSON, J. P. LORIA, A. D. MIRANKER, JOURNAL OF 
MOLECULAR BIOLOGY 2009, 393, 383-396. 
[32] Y. A. DOMANOV, P. K. J. KINNUNEN, JOURNAL OF MOLECULAR 
BIOLOGY 2008, 376, 42-54. 
[33] M. F. M. ENGEL, CHEMISTRY AND PHYSICS OF LIPIDS 2009, 
160, 1-10. 
[34] S. LUCA, W.-M. YAU, R. LEAPMAN, R. TYCKO, BIOCHEMISTRY 
2007, 46, 13505-13522. 
[35] J. J. W. WILTZIUS, S. A. SIEVERS, M. R. SAWAYA, D. EISEN-
BERG, PROTEIN SCI 2009, 18, 1521-1530. 
[36] W. HOFFMANN, K. FOLMERT, J. MOSCHNER, X. HUANG, H. VON 
BERLEPSCH, B. KOKSCH, M. T. BOWERS, G. VON HELDEN, K. PAGEL, 
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2018, 140, 244-249. 
[37] A. L. SERRANO, J. P. LOMONT, L.-H. TU, D. P. RALEIGH, M. T. 
ZANNI, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2017, 139, 
16748-16758. 
[38] L. E. BUCHANAN, E. B. DUNKELBERGER, H. Q. TRAN, P.-N. 
CHENG, C.-C. CHIU, P. CAO, D. P. RALEIGH, J. J. DE PABLO, J. S. 
NOWICK, M. T. ZANNI, PROCEEDINGS OF THE NATIONAL ACADEMY OF 
SCIENCES 2013, 110, 19285-19290. 
[39] L. M. YOUNG, P. CAO, D. P. RALEIGH, A. E. ASHCROFT, S. E. 
RADFORD, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2014, 136, 
660-670. 
[40] G. NARDAI, T. KORCSMÁROS, E. PAPP, P. CSERMELY, BIOFAC-
TORS 2003, 17, 259-267. 
[41] D. C. RODRIGUEZ CAMARGO, K. TRIPSIANES, K. BUDAY, A. 
FRANKO, C. GÖBL, C. HARTLMÜLLER, R. SARKAR, M. AICHLER, G. MET-
TENLEITER, M. SCHULZ, A. BÖDDRICH, C. ERCK, H. MARTENS, A. K. 
WALCH, T. MADL, E. E. WANKER, M. CONRAD, M. H. DE ANGELIS, B. 
REIF, SCIENTIFIC REPORTS 2017, 7, 44041. 
[42] J. A. WILLIAMSON, A. D. MIRANKER, PROTEIN SCI 2007, 16, 
110-117. 
[43] R. P. R. NANGA, J. R. BRENDER, S. VIVEKANANDAN, A. 
RAMAMOORTHY, BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - 
BIOMEMBRANES 2011, 1808, 2337-2342. 
[44] N. F. DUPUIS, C. WU, J.-E. SHEA, M. T. BOWERS, JOURNAL OF 
THE AMERICAN CHEMICAL SOCIETY 2011, 133, 7240-7243. 
[45] R. KAYED, J. BERNHAGEN, N. GREENFIELD, K. SWEIMEH, H. 
BRUNNER, W. VOELTER, A. KAPURNIOTU, JOURNAL OF MOLECULAR BI-
OLOGY 1999, 287, 781-796. 
 VIII 
[46] S.-H. SHIM, R. GUPTA, Y. L. LING, D. B. STRASFELD, D. P. RA-
LEIGH, M. T. ZANNI, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCI-
ENCES 2009, 106, 6614. 
[47] A. S. REDDY, L. WANG, S. SINGH, Y. L. LING, L. BUCHANAN, M. 
T. ZANNI, J. L. SKINNER, J. J. DE PABLO, BIOPHYSICAL JOURNAL 2010, 
99, 2208-2216. 
[48] Y. SUN, A. KAKINEN, Y. XING, E. H. PILKINGTON, T. P. DAVIS, 
P. C. KE, F. DING, BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - MOLECU-
LAR BASIS OF DISEASE 2019, 1865, 434-444. 
[49] Y. SUN, A. KAKINEN, Y. XING, P. FARIDI, A. NANDAKUMAR, A. 
W. PURCELL, T. P. DAVIS, P. C. KE, F. DING, SMALL 2019, 15, 
1805166. 
[50] A. LAGANOWSKY, C. LIU, M. R. SAWAYA, J. P. WHITELEGGE, J. 
PARK, M. ZHAO, A. PENSALFINI, A. B. SORIAGA, M. LANDAU, P. K. TENG, 
D. CASCIO, C. GLABE, D. EISENBERG, SCIENCE 2012, 335, 1228. 
[51] T. D. DO, N. E. LAPOINTE, R. NELSON, P. KROTEE, E. Y. HAY-
DEN, B. ULRICH, S. QUAN, S. C. FEINSTEIN, D. B. TEPLOW, D. EISEN-
BERG, J.-E. SHEA, M. T. BOWERS, JOURNAL OF THE AMERICAN CHEMI-
CAL SOCIETY 2016, 138, 549-557. 
[52] Y. SUN, B. WANG, X. GE, F. DING, PHYSICAL CHEMISTRY 
CHEMICAL PHYSICS 2017, 19, 28414-28423. 
[53] A. QUIST, I. DOUDEVSKI, H. LIN, R. AZIMOVA, D. NG, B. FRAN-
GIONE, B. KAGAN, J. GHISO, R. LAL, PROCEEDINGS OF THE NATIONAL 
ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 2005, 102, 
10427. 
[54] C. S. GOLDSBURY, G. J. S. COOPER, K. N. GOLDIE, S. A. MÜL-
LER, E. L. SAAFI, W. T. M. GRUIJTERS, M. P. MISUR, A. ENGEL, U. AEBI, 
J. KISTLER, JOURNAL OF STRUCTURAL BIOLOGY 1997, 119, 17-27. 
[55] J. R. BRENDER, E. L. LEE, K. HARTMAN, P. T. WONG, A. 
RAMAMOORTHY, D. G. STEEL, A. GAFNI, BIOPHYSICAL JOURNAL 2011, 
100, 685-692. 
[56] A. I. ILITCHEV, M. J. GIAMMONA, J. N. SCHWARZE, S. K. BU-
RATTO, M. T. BOWERS, THE JOURNAL OF PHYSICAL CHEMISTRY B 2018, 
122, 9852-9859. 
[57] S. SALAMEKH, J. R. BRENDER, S.-J. HYUNG, R. P. R. NANGA, 
S. VIVEKANANDAN, B. T. RUOTOLO, A. RAMAMOORTHY, JOURNAL OF 
MOLECULAR BIOLOGY 2011, 410, 294-306. 
[58] E. ATRIÁN-BLASCO, P. GONZALEZ, A. SANTORO, B. ALIES, P. 
FALLER, C. HUREAU, COORDINATION CHEMISTRY REVIEWS 2018, 371, 
38-55. 
[59] M. ROWIŃSKA-ŻYREK, DALTON TRANSACTIONS 2016, 45, 
8099-8106. 
[60] J. R. BRENDER, K. HARTMAN, R. P. R. NANGA, N. POPOVYCH, 
R. DE LA SALUD BEA, S. VIVEKANANDAN, E. N. G. MARSH, A. RAMA-
MOORTHY, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY 2010, 132, 
8973-8983. 
[61] J. R. BRENDER, J. KRISHNAMOORTHY, G. M. L. MESSINA, A. 
DEB, S. VIVEKANANDAN, C. LA ROSA, J. E. PENNER-HAHN, A. RAMA-
MOORTHY, CHEMICAL COMMUNICATIONS 2013, 49, 3339-3341. 
[62] P. NEDUMPULLY-GOVINDAN, Y. YANG, R. ANDORFER, W. CAO, 
F. DING, BIOCHEMISTRY 2015, 54, 7335-7344. 
[63] A. MASAD, L. HAYES, B. J. TABNER, S. TURNBULL, L. J. 
COOPER, N. J. FULLWOOD, M. J. GERMAN, F. KAMETANI, O. M. A. EL-
AGNAF, D. ALLSOP, FEBS LETTERS 2007, 581, 3489-3493. 
[64] Y.-P. YU, P. LEI, J. HU, W.-H. WU, Y.-F. ZHAO, Y.-M. LI, CHE-
MICAL COMMUNICATIONS 2010, 46, 6909-6911. 
 IX 
[65] I. RIBA, P. E. BARRAN, G. J. S. COOPER, R. D. UNWIN, INTER-
NATIONAL JOURNAL OF MASS SPECTROMETRY 2015, 391, 47-53. 
[66] C. SÁNCHEZ-LÓPEZ, R. CORTÉS-MEJÍA, M. C. MIOTTO, A. 
BINOLFI, C. O. FERNÁNDEZ, J. M. DEL CAMPO, L. QUINTANAR, 
INORGANIC CHEMISTRY 2016, 55, 10727-10740. 
[67] S. J. C. LEE, T. S. CHOI, J. W. LEE, H. J. LEE, D.-G. MUN, S. 
AKASHI, S.-W. LEE, M. H. LIM, H. I. KIM, CHEMICAL SCIENCE 2016, 7, 
5398-5406. 
[68] M.-J. KIM, H.-T. KIM, EUROPEAN JOURNAL OF MASS SPEC-
TROMETRY 2012, 18, 51-58. 
[69] A. MAGRÌ, D. LA MENDOLA, V. G. NICOLETTI, G. PAPPALARDO, 
E. RIZZARELLI, CHEMISTRY – A EUROPEAN JOURNAL 2016, 22, 13287-
13300. 
[70] H. LI, E. HA, R. P. DONALDSON, A. M. JEREMIC, A. VERTES, 
ANALYTICAL CHEMISTRY 2015, 87, 9829-9837. 
[71] IN FOURIER TRANSFORM INFRARED SPECTROMETRY, PP. 19-
55. 
[72] A. BARTH, BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - BIOENER-
GETICS 2007, 1767, 1073-1101. 
[73] IN FOURIER TRANSFORM INFRARED SPECTROMETRY, PP. 321-
348. 
[74] S. E. GLASSFORD, B. BYRNE, S. G. KAZARIAN, BIOCHIMICA ET 
BIOPHYSICA ACTA (BBA) - PROTEINS AND PROTEOMICS 2013, 1834, 
2849-2858. 
[75] A. M. RIJS, J. L. ALONSO, GAS-PHASE IR SPECTROSCOPY AND 
STRUCTURE OF BIOLOGICAL MOLECULES / ANOUK M. RIJS 
... EDS. WITH CONTRIBUTIONS BY J. L. ALONSO, SPRINGER, CHAM [U.A.], 
2015. 
[76] J. OOMENS, B. G. SARTAKOV, G. MEIJER, G. VON HELDEN, IN-
TERNATIONAL JOURNAL OF MASS SPECTROMETRY 2006, 254, 1-19. 
[77] P. Y. CHOU, G. D. FASMAN, BIOCHEMISTRY 1974, 13, 222-245. 
[78] M. F. JARROLD, PHYSICAL CHEMISTRY CHEMICAL PHYSICS 
2007, 9, 1659-1671. 
[79] R. R. HUDGINS, M. A. RATNER, M. F. JARROLD, JOURNAL OF 
THE AMERICAN CHEMICAL SOCIETY 1998, 120, 12974-12975. 
[80] F. SCHUBERT, M. ROSSI, C. BALDAUF, K. PAGEL, S. WARNKE, 
G. VON HELDEN, F. FILSINGER, P. KUPSER, G. MEIJER, M. SALWICZEK, 
B. KOKSCH, M. SCHEFFLER, V. BLUM, PHYSICAL CHEMISTRY CHEMICAL 
PHYSICS 2015, 17, 7373-7385. 
[81] M. ROSSI, V. BLUM, P. KUPSER, G. VON HELDEN, F. BIERAU, K. 
PAGEL, G. MEIJER, M. SCHEFFLER, THE JOURNAL OF PHYSICAL CHEM-
ISTRY LETTERS 2010, 1, 3465-3470. 
[82] L. VÉRTESY, V. OEDING, R. BENDER, K. ZEPF, G. NESEMANN, 
EUROPEAN JOURNAL OF BIOCHEMISTRY 1984, 141, 505-512. 
[83] A. D. KLINE, W. BRAUN, K. WÜTHRICH, JOURNAL OF 
MOLECULAR BIOLOGY 1988, 204, 675-724. 
[84] S. WARNKE, G. VON HELDEN, K. PAGEL, JOURNAL OF THE 
AMERICAN CHEMICAL SOCIETY 2013, 135, 1177-1180. 
[85] C. ZSCHERP, H. AYGÜN, J. W. ENGELS, W. MÄNTELE, BIO-
CHIMICA ET BIOPHYSICA ACTA (BBA) - PROTEINS AND PROTEOMICS 
2003, 1651, 139-145. 
[86] H. JANG, FERNANDO T. ARCE, M. MUSTATA, S. RAMA-
CHANDRAN, R. CAPONE, R. NUSSINOV, R. LAL, BIOPHYSICAL JOURNAL 
2011, 100, 1775-1783. 
[87] S. S. L. HARWIG, A. WARING, H. J. YANG, Y. CHO, L. TAN, R. I. 
LEHRER, EUROPEAN JOURNAL OF BIOCHEMISTRY 1996, 240, 352-357. 
 X 
[88] D. GIDALEVITZ, Y. ISHITSUKA, A. S. MURESAN, O. KONOVALOV, 
A. J. WARING, R. I. LEHRER, K. Y. C. LEE, PROCEEDINGS OF THE NA-
TIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 
2003, 100, 6302-6307. 
[89] W. T. HELLER, A. J. WARING, R. I. LEHRER, H. W. HUANG, BI-
OCHEMISTRY 1998, 37, 17331-17338. 
[90] R. CAPONE, M. MUSTATA, H. JANG, F. T. ARCE, R. NUSSINOV, 
R. LAL, BIOPHYSICAL JOURNAL 2010, 98, 2644-2652. 
[91] M. SVOBODA, W. MEISTER, W. VETTER, JOURNAL OF MASS 
SPECTROMETRY 1995, 30, 1562-1566. 
[92] R. R. JULIAN, M. AKIN, J. A. MAY, B. M. STOLTZ, J. L. BEAU-
CHAMP, INTERNATIONAL JOURNAL OF MASS SPECTROMETRY 2002, 220, 
87-96. 
[93] R. L. FAHRNER, T. DIECKMANN, S. S. L. HARWIG, R. I. LEHRER, 
D. EISENBERG, J. FEIGON, CHEMISTRY & BIOLOGY 1996, 3, 543-550. 
[94] H. JANG, B. MA, R. NUSSINOV, BMC STRUCTURAL BIOLOGY 
2007, 7, 21. 
[95] J. KUBELKA, T. A. KEIDERLING, JOURNAL OF THE AMERICAN 
CHEMICAL SOCIETY 2001, 123, 12048-12058. 
[96] A. E. BUTLER, J. JANG, T. GURLO, M. D. CARTY, W. C. 
SOELLER, P. C. BUTLER, A NEW MODEL FOR TYPE 2 DIABETES 2004, 
53, 1509-1516. 
[97] A. I. ILITCHEV, M. J. GIAMMONA, C. OLIVAS, S. L. CLAUD, K. L. 
LAZAR CANTRELL, C. WU, S. K. BURATTO, M. T. BOWERS, JOURNAL OF 
THE AMERICAN CHEMICAL SOCIETY 2018, 140, 9685-9695. 
[98] P. LIU, S. ZHANG, M.-S. CHEN, Q. LIU, C. WANG, C. WANG, Y.-
M. LI, F. BESENBACHER, M. DONG, CHEMICAL COMMUNICATIONS 2012, 
48, 191-193. 
[99] A. C. SUSA, C. WU, S. L. BERNSTEIN, N. F. DUPUIS, H. WANG, 
D. P. RALEIGH, J.-E. SHEA, M. T. BOWERS, JOURNAL OF THE AMERICAN 
CHEMICAL SOCIETY 2014, 136, 12912-12919. 
[100] F. CHITI, C. M. DOBSON, ANNUAL REVIEW OF BIOCHEMISTRY 





Table A1. Correlations between amide I frequencies and secondary structure[72]. 
Secondary structure Amide I band (cm-1) 
Aggressed strands 1620–1628 
-sheet 1610–1640 
Random coil 1640–1648 
-Helix 1648–1660 
310-Helix, type II -turn 1660–1685 





A1. nESI time-of-flight of tendamistat solution. 
 XII 
 
A2. nESI time-of-flight of PG-1 solution. 
 XIII 
 
A3. ATDs of PG-1 and PG-1-db30c10 adducts. All the ATDs were obtained from the solution con-
taining crown ether. 
 XIV 
 
A4. nESI time-of-flight of rIAPP solution. 
 







1 2 1 1348 367 
1 2 2 1616 401 
1 2 3 1884 425 
1 3 1 899 471 
1 3 3 1256 535 
1 3 4 1435 605 
1 5 2 646 640 
1 5 5 968 869 
 
 




A5. Primary sequence of PrP106–126. 
 
A6. nESI time-of-flight of the 25 M: 25 M solution hIAPP:PrP106–126 
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A7. nESI time-of-flight of the 25 M: 25 M solution rIAPP:PrP106–126 
 
 
A8. nESI time-of-flight mass spectra of a 1:1 mixture of hIAPP and VEALYL. 
 
